{"entity":"merck","id":"ent_merck","name":"Merck & Co.","wikidata":"Q247489","page":"https://asof.is/record/merck","summary":"Merck & Co. is an American multinational pharmaceutical company, headquartered in Rahway. It reported revenue of $65.01B for the period ended December 31, 2025.","title":"Merck & Co.: revenue $65.01B","key_facts":[{"label":"Headquarters","value":"Rahway","claim":"clm_BFFD023A5D40"},{"label":"Revenue","value":"$65.01B","recorded":"65,011,000,000 United States dollar","note":"to 2025-12-31","claim":"clm_E778C75FD821"},{"label":"Ticker","value":"MRK · NYSE","claim":"clm_37834FC2D131"}],"faq":[{"question":"Where is Merck & Co. headquartered?","answer":"Rahway."},{"question":"What is Merck & Co.'s revenue?","answer":"$65.01B for the period ended December 31, 2025."}],"as_of":null,"known_by":null,"since":null,"fact_pages":[{"predicate":"headquarters","page":"https://asof.is/record/merck/headquarters","md":"https://asof.is/record/merck/headquarters.md","json":"https://asof.is/v1/entities/merck/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/merck/revenue","md":"https://asof.is/record/merck/revenue.md","json":"https://asof.is/v1/entities/merck/revenue"},{"predicate":"net_income","page":"https://asof.is/record/merck/net_income","md":"https://asof.is/record/merck/net_income.md","json":"https://asof.is/v1/entities/merck/net_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/merck/quarterly_revenue","md":"https://asof.is/record/merck/quarterly_revenue.md","json":"https://asof.is/v1/entities/merck/quarterly_revenue"}],"products":[],"coverage":{"entity":"merck","name":"Merck & Co.","kind":"organization","sources":[{"source":"wikidata","item":"Q247489","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":310158,"ticker":"MRK","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":503,"open":20,"retracted":0,"first":"1891-01-01","predicates":{"quarterly_research_and_development":{"claims":56,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"total_assets":{"claims":71,"open":1,"kind":"fact"},"net_income":{"claims":19,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":38,"open":1,"kind":"fact"},"quarterly_net_income":{"claims":56,"open":1,"kind":"fact"},"research_and_development":{"claims":19,"open":1,"kind":"fact"},"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"revenue":{"claims":14,"open":1,"kind":"fact"},"total_equity":{"claims":73,"open":1,"kind":"fact"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"cik":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":501,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":2,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_B0FE93A73A8D","predicate":"shares_outstanding","value":"2,465,245,688 shares","valid_from":"2026-10-31","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,465,245,688 shares\", as of 2026-10-31. Claim clm_B0FE93A73A8D, https://asof.is/claim/clm_B0FE93A73A8D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_B0FE93A73A8D","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_23DBC8C334E1","predicate":"total_equity","value":"44,893,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,893,000,000 United States dollar\", as of 2026-09-30. Claim clm_23DBC8C334E1, https://asof.is/claim/clm_23DBC8C334E1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_23DBC8C334E1","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_5760FE8DF5CC","predicate":"cash_and_equivalents","value":"9,550,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,550,000,000 United States dollar\", as of 2026-09-30. Claim clm_5760FE8DF5CC, https://asof.is/claim/clm_5760FE8DF5CC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_5760FE8DF5CC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_700C48638C17","predicate":"total_assets","value":"132,773,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 132,773,000,000 United States dollar\", as of 2026-09-30. Claim clm_700C48638C17, https://asof.is/claim/clm_700C48638C17, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_700C48638C17","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_8D15B1B2A78D","predicate":"quarterly_research_and_development","value":"4,537,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,537,000,000 United States dollar\", as of 2026-09-30. Claim clm_8D15B1B2A78D, https://asof.is/claim/clm_8D15B1B2A78D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_8D15B1B2A78D","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_BE2114005849","predicate":"quarterly_net_income","value":"5,065,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,065,000,000 United States dollar\", as of 2026-09-30. Claim clm_BE2114005849, https://asof.is/claim/clm_BE2114005849, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_BE2114005849","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_D93F566AE261","predicate":"quarterly_revenue","value":"18,085,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 18,085,000,000 United States dollar\", as of 2026-09-30. Claim clm_D93F566AE261, https://asof.is/claim/clm_D93F566AE261, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_D93F566AE261","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_551368D9DFD9","predicate":"shares_outstanding","value":"2,467,171,638 shares","valid_from":"2026-07-31","valid_to":"2026-10-31","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,467,171,638 shares\", as of 2026-07-31 (until 2026-10-31). Claim clm_551368D9DFD9, https://asof.is/claim/clm_551368D9DFD9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_551368D9DFD9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B0FE93A73A8D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_1D21FB857339","predicate":"total_assets","value":"129,802,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 129,802,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1D21FB857339, https://asof.is/claim/clm_1D21FB857339, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_1D21FB857339","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_700C48638C17","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_3CFDEE3E892F","predicate":"quarterly_net_income","value":"-1,335,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -1,335,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_3CFDEE3E892F, https://asof.is/claim/clm_3CFDEE3E892F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_3CFDEE3E892F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BE2114005849","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_56023EED76B1","predicate":"total_equity","value":"41,933,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 41,933,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_56023EED76B1, https://asof.is/claim/clm_56023EED76B1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_56023EED76B1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_23DBC8C334E1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_59257F264468","predicate":"quarterly_revenue","value":"16,607,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,607,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_59257F264468, https://asof.is/claim/clm_59257F264468, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_59257F264468","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D93F566AE261","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_6963A9FE29D9","predicate":"quarterly_research_and_development","value":"9,741,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 9,741,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_6963A9FE29D9, https://asof.is/claim/clm_6963A9FE29D9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_6963A9FE29D9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8D15B1B2A78D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_9B76B2EBE76B","predicate":"cash_and_equivalents","value":"6,849,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,849,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_9B76B2EBE76B, https://asof.is/claim/clm_9B76B2EBE76B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_9B76B2EBE76B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5760FE8DF5CC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-08-07"}},{"id":"clm_3D54FBDF161B","predicate":"shares_outstanding","value":"2,469,824,415 shares","valid_from":"2026-04-30","valid_to":"2026-07-31","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,469,824,415 shares\", as of 2026-04-30 (until 2026-07-31). Claim clm_3D54FBDF161B, https://asof.is/claim/clm_3D54FBDF161B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_3D54FBDF161B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_551368D9DFD9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_052408C1DABC","predicate":"quarterly_net_income","value":"-4,240,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -4,240,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_052408C1DABC, https://asof.is/claim/clm_052408C1DABC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_052408C1DABC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3CFDEE3E892F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_2EAD708A2D4D","predicate":"total_equity","value":"45,878,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,878,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_2EAD708A2D4D, https://asof.is/claim/clm_2EAD708A2D4D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_2EAD708A2D4D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_56023EED76B1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_4EF7F384C3E5","predicate":"cash_and_equivalents","value":"5,327,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,327,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_4EF7F384C3E5, https://asof.is/claim/clm_4EF7F384C3E5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_4EF7F384C3E5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9B76B2EBE76B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_6DF831C7A399","predicate":"total_assets","value":"128,685,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 128,685,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_6DF831C7A399, https://asof.is/claim/clm_6DF831C7A399, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_6DF831C7A399","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D21FB857339","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_A5059DD1C3C6","predicate":"quarterly_revenue","value":"16,286,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,286,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_A5059DD1C3C6, https://asof.is/claim/clm_A5059DD1C3C6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_A5059DD1C3C6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59257F264468","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_CC42DDED77FE","predicate":"quarterly_research_and_development","value":"12,592,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 12,592,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_CC42DDED77FE, https://asof.is/claim/clm_CC42DDED77FE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_CC42DDED77FE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6963A9FE29D9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-05-04"}},{"id":"clm_816D1195758B","predicate":"shares_outstanding","value":"2,472,392,003 shares","valid_from":"2026-01-31","valid_to":"2026-04-30","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,472,392,003 shares\", as of 2026-01-31 (until 2026-04-30). Claim clm_816D1195758B, https://asof.is/claim/clm_816D1195758B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_816D1195758B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3D54FBDF161B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_062934F11209","predicate":"research_and_development","value":"15,789,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 15,789,000,000 United States dollar\", as of 2025-12-31. Claim clm_062934F11209, https://asof.is/claim/clm_062934F11209, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_062934F11209","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_23107EF0C145","predicate":"net_income","value":"18,254,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 18,254,000,000 United States dollar\", as of 2025-12-31. Claim clm_23107EF0C145, https://asof.is/claim/clm_23107EF0C145, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_23107EF0C145","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_4011DB45C7C0","predicate":"total_equity","value":"52,606,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 52,606,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_4011DB45C7C0, https://asof.is/claim/clm_4011DB45C7C0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_4011DB45C7C0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2EAD708A2D4D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_4A91E3E067AC","predicate":"total_assets","value":"136,866,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 136,866,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_4A91E3E067AC, https://asof.is/claim/clm_4A91E3E067AC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_4A91E3E067AC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6DF831C7A399","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_DB573F068746","predicate":"cash_and_equivalents","value":"14,565,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,565,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_DB573F068746, https://asof.is/claim/clm_DB573F068746, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_DB573F068746","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4EF7F384C3E5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_E778C75FD821","predicate":"revenue","value":"65,011,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 65,011,000,000 United States dollar\", as of 2025-12-31. Claim clm_E778C75FD821, https://asof.is/claim/clm_E778C75FD821, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_E778C75FD821","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_216265EA32A0","predicate":"shares_outstanding","value":"2,482,022,536 shares","valid_from":"2025-10-31","valid_to":"2026-01-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,482,022,536 shares\", as of 2025-10-31 (until 2026-01-31). Claim clm_216265EA32A0, https://asof.is/claim/clm_216265EA32A0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_216265EA32A0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_816D1195758B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_44C6DC623BB5","predicate":"quarterly_net_income","value":"5,785,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,785,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_44C6DC623BB5, https://asof.is/claim/clm_44C6DC623BB5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_44C6DC623BB5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_052408C1DABC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_7F62C5E7C6D5","predicate":"total_assets","value":"129,546,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 129,546,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_7F62C5E7C6D5, https://asof.is/claim/clm_7F62C5E7C6D5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_7F62C5E7C6D5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4A91E3E067AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_86C0BCF4E479","predicate":"quarterly_revenue","value":"17,276,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 17,276,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_86C0BCF4E479, https://asof.is/claim/clm_86C0BCF4E479, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_86C0BCF4E479","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5059DD1C3C6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_BDAEC6471AF2","predicate":"total_equity","value":"51,850,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 51,850,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_BDAEC6471AF2, https://asof.is/claim/clm_BDAEC6471AF2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_BDAEC6471AF2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4011DB45C7C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_C86D1A2441BE","predicate":"cash_and_equivalents","value":"18,169,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 18,169,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C86D1A2441BE, https://asof.is/claim/clm_C86D1A2441BE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_C86D1A2441BE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DB573F068746","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_E7C205B81C1E","predicate":"quarterly_research_and_development","value":"4,234,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,234,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_E7C205B81C1E, https://asof.is/claim/clm_E7C205B81C1E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_E7C205B81C1E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CC42DDED77FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-11-05"}},{"id":"clm_DF652357EB7C","predicate":"shares_outstanding","value":"2,497,783,211 shares","valid_from":"2025-07-31","valid_to":"2025-10-31","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,497,783,211 shares\", as of 2025-07-31 (until 2025-10-31). Claim clm_DF652357EB7C, https://asof.is/claim/clm_DF652357EB7C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_DF652357EB7C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_216265EA32A0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_6E0F8CB5C8F7","predicate":"quarterly_research_and_development","value":"4,048,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,048,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_6E0F8CB5C8F7, https://asof.is/claim/clm_6E0F8CB5C8F7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_6E0F8CB5C8F7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E7C205B81C1E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_9989FAB3CB44","predicate":"cash_and_equivalents","value":"8,007,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,007,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_9989FAB3CB44, https://asof.is/claim/clm_9989FAB3CB44, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_9989FAB3CB44","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C86D1A2441BE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_A023A3BF80C0","predicate":"quarterly_revenue","value":"15,806,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,806,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_A023A3BF80C0, https://asof.is/claim/clm_A023A3BF80C0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_A023A3BF80C0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_86C0BCF4E479","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_CB2E2563DBAE","predicate":"quarterly_net_income","value":"4,427,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,427,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_CB2E2563DBAE, https://asof.is/claim/clm_CB2E2563DBAE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_CB2E2563DBAE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_44C6DC623BB5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_CD7198CC2749","predicate":"total_equity","value":"48,993,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,993,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_CD7198CC2749, https://asof.is/claim/clm_CD7198CC2749, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_CD7198CC2749","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BDAEC6471AF2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_FF7386E5859A","predicate":"total_assets","value":"117,523,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,523,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_FF7386E5859A, https://asof.is/claim/clm_FF7386E5859A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_FF7386E5859A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7F62C5E7C6D5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-08-05"}},{"id":"clm_37C45B0F3389","predicate":"shares_outstanding","value":"2,511,031,253 shares","valid_from":"2025-04-30","valid_to":"2025-07-31","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,511,031,253 shares\", as of 2025-04-30 (until 2025-07-31). Claim clm_37C45B0F3389, https://asof.is/claim/clm_37C45B0F3389, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_37C45B0F3389","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DF652357EB7C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_2B02E20CD535","predicate":"total_equity","value":"48,335,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,335,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_2B02E20CD535, https://asof.is/claim/clm_2B02E20CD535, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_2B02E20CD535","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD7198CC2749","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_6E7A454B6848","predicate":"cash_and_equivalents","value":"8,629,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,629,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_6E7A454B6848, https://asof.is/claim/clm_6E7A454B6848, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_6E7A454B6848","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9989FAB3CB44","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_788ACEC11B0D","predicate":"quarterly_research_and_development","value":"3,621,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,621,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_788ACEC11B0D, https://asof.is/claim/clm_788ACEC11B0D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_788ACEC11B0D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E0F8CB5C8F7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_9639B624984C","predicate":"quarterly_revenue","value":"15,529,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,529,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9639B624984C, https://asof.is/claim/clm_9639B624984C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_9639B624984C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A023A3BF80C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_A6351EF8D62A","predicate":"total_assets","value":"115,122,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 115,122,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_A6351EF8D62A, https://asof.is/claim/clm_A6351EF8D62A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_A6351EF8D62A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF7386E5859A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_D254D3EB3376","predicate":"quarterly_net_income","value":"5,079,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,079,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_D254D3EB3376, https://asof.is/claim/clm_D254D3EB3376, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_D254D3EB3376","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CB2E2563DBAE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-02"}},{"id":"clm_F14BC63CE196","predicate":"shares_outstanding","value":"2,526,036,240 shares","valid_from":"2025-01-31","valid_to":"2025-04-30","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,526,036,240 shares\", as of 2025-01-31 (until 2025-04-30). Claim clm_F14BC63CE196, https://asof.is/claim/clm_F14BC63CE196, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_F14BC63CE196","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_37C45B0F3389","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_10EEDDF5060A","predicate":"total_assets","value":"117,106,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,106,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_10EEDDF5060A, https://asof.is/claim/clm_10EEDDF5060A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_10EEDDF5060A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A6351EF8D62A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_5998C6109ED8","predicate":"total_equity","value":"46,313,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,313,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_5998C6109ED8, https://asof.is/claim/clm_5998C6109ED8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_5998C6109ED8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2B02E20CD535","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_836E3FCB29EF","predicate":"cash_and_equivalents","value":"13,242,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,242,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_836E3FCB29EF, https://asof.is/claim/clm_836E3FCB29EF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_836E3FCB29EF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E7A454B6848","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_B00A59ED1285","predicate":"revenue","value":"64,168,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 64,168,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B00A59ED1285, https://asof.is/claim/clm_B00A59ED1285, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B00A59ED1285","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E778C75FD821","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_B017880F2FAE","predicate":"research_and_development","value":"17,938,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 17,938,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B017880F2FAE, https://asof.is/claim/clm_B017880F2FAE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B017880F2FAE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_062934F11209","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_C6B723CD22D3","predicate":"net_income","value":"17,117,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 17,117,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_C6B723CD22D3, https://asof.is/claim/clm_C6B723CD22D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_C6B723CD22D3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_23107EF0C145","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-25"}},{"id":"clm_EF29FF74A1DA","predicate":"shares_outstanding","value":"2,529,635,645 shares","valid_from":"2024-10-31","valid_to":"2025-01-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,529,635,645 shares\", as of 2024-10-31 (until 2025-01-31). Claim clm_EF29FF74A1DA, https://asof.is/claim/clm_EF29FF74A1DA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_EF29FF74A1DA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F14BC63CE196","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_32776455365F","predicate":"cash_and_equivalents","value":"14,593,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,593,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_32776455365F, https://asof.is/claim/clm_32776455365F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_32776455365F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_836E3FCB29EF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_452ECF596A5A","predicate":"total_equity","value":"44,502,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,502,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_452ECF596A5A, https://asof.is/claim/clm_452ECF596A5A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_452ECF596A5A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5998C6109ED8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_7D92F6A5B925","predicate":"quarterly_net_income","value":"3,157,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,157,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_7D92F6A5B925, https://asof.is/claim/clm_7D92F6A5B925, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_7D92F6A5B925","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D254D3EB3376","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_81BBE85997B1","predicate":"quarterly_revenue","value":"16,657,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,657,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_81BBE85997B1, https://asof.is/claim/clm_81BBE85997B1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_81BBE85997B1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9639B624984C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_A6EF3EF9F17B","predicate":"total_assets","value":"117,532,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,532,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A6EF3EF9F17B, https://asof.is/claim/clm_A6EF3EF9F17B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_A6EF3EF9F17B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_10EEDDF5060A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_EF9F40E4249B","predicate":"quarterly_research_and_development","value":"5,862,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 5,862,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_EF9F40E4249B, https://asof.is/claim/clm_EF9F40E4249B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_EF9F40E4249B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_788ACEC11B0D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_CA8B975E05B4","predicate":"shares_outstanding","value":"2,534,809,312 shares","valid_from":"2024-07-31","valid_to":"2024-10-31","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,534,809,312 shares\", as of 2024-07-31 (until 2024-10-31). Claim clm_CA8B975E05B4, https://asof.is/claim/clm_CA8B975E05B4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_CA8B975E05B4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EF29FF74A1DA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_0F3839AEFD94","predicate":"total_assets","value":"112,630,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 112,630,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_0F3839AEFD94, https://asof.is/claim/clm_0F3839AEFD94, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_0F3839AEFD94","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A6EF3EF9F17B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_34EB6E01BD4E","predicate":"total_equity","value":"43,582,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,582,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_34EB6E01BD4E, https://asof.is/claim/clm_34EB6E01BD4E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_34EB6E01BD4E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_452ECF596A5A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_53A19AADAE82","predicate":"cash_and_equivalents","value":"11,304,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,304,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_53A19AADAE82, https://asof.is/claim/clm_53A19AADAE82, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_53A19AADAE82","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_32776455365F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_64E8125CC2B5","predicate":"quarterly_research_and_development","value":"3,500,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,500,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_64E8125CC2B5, https://asof.is/claim/clm_64E8125CC2B5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_64E8125CC2B5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EF9F40E4249B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_9D2EE4822EFB","predicate":"quarterly_net_income","value":"5,455,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,455,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_9D2EE4822EFB, https://asof.is/claim/clm_9D2EE4822EFB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_9D2EE4822EFB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7D92F6A5B925","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_CA3727C7A4E6","predicate":"quarterly_revenue","value":"16,112,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,112,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_CA3727C7A4E6, https://asof.is/claim/clm_CA3727C7A4E6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_CA3727C7A4E6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81BBE85997B1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-08-05"}},{"id":"clm_84C234FF7850","predicate":"shares_outstanding","value":"2,532,806,307 shares","valid_from":"2024-04-30","valid_to":"2024-07-31","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,806,307 shares\", as of 2024-04-30 (until 2024-07-31). Claim clm_84C234FF7850, https://asof.is/claim/clm_84C234FF7850, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_84C234FF7850","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA8B975E05B4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_19ED07FEF676","predicate":"quarterly_net_income","value":"4,762,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,762,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_19ED07FEF676, https://asof.is/claim/clm_19ED07FEF676, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_19ED07FEF676","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9D2EE4822EFB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_61D652C2AA20","predicate":"cash_and_equivalents","value":"5,579,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,579,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_61D652C2AA20, https://asof.is/claim/clm_61D652C2AA20, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_61D652C2AA20","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53A19AADAE82","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_8611BE831E10","predicate":"quarterly_revenue","value":"15,775,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,775,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_8611BE831E10, https://asof.is/claim/clm_8611BE831E10, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_8611BE831E10","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA3727C7A4E6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_866522253978","predicate":"total_equity","value":"40,364,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,364,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_866522253978, https://asof.is/claim/clm_866522253978, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_866522253978","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_34EB6E01BD4E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_BDB2E27B4E60","predicate":"total_assets","value":"105,849,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,849,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_BDB2E27B4E60, https://asof.is/claim/clm_BDB2E27B4E60, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_BDB2E27B4E60","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0F3839AEFD94","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_DD2E2358C2C5","predicate":"quarterly_research_and_development","value":"3,992,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,992,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_DD2E2358C2C5, https://asof.is/claim/clm_DD2E2358C2C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_DD2E2358C2C5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_64E8125CC2B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2024, filed 2024-05-03"}},{"id":"clm_95A1CC25AF02","predicate":"shares_outstanding","value":"2,532,643,872 shares","valid_from":"2024-01-31","valid_to":"2024-04-30","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,643,872 shares\", as of 2024-01-31 (until 2024-04-30). Claim clm_95A1CC25AF02, https://asof.is/claim/clm_95A1CC25AF02, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_95A1CC25AF02","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_84C234FF7850","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_00E79EEE61A1","predicate":"net_income","value":"365,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 365,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_00E79EEE61A1, https://asof.is/claim/clm_00E79EEE61A1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_00E79EEE61A1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C6B723CD22D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_26E68DAA6E4F","predicate":"total_assets","value":"106,675,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,675,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_26E68DAA6E4F, https://asof.is/claim/clm_26E68DAA6E4F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_26E68DAA6E4F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BDB2E27B4E60","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_8B721020A859","predicate":"cash_and_equivalents","value":"6,841,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,841,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_8B721020A859, https://asof.is/claim/clm_8B721020A859, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_8B721020A859","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_61D652C2AA20","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_9F3A2514948A","predicate":"research_and_development","value":"30,531,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 30,531,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_9F3A2514948A, https://asof.is/claim/clm_9F3A2514948A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_9F3A2514948A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B017880F2FAE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_ABA0DDBCEC64","predicate":"revenue","value":"60,115,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 60,115,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_ABA0DDBCEC64, https://asof.is/claim/clm_ABA0DDBCEC64, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_ABA0DDBCEC64","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B00A59ED1285","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_D509213C3811","predicate":"total_equity","value":"37,581,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 37,581,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_D509213C3811, https://asof.is/claim/clm_D509213C3811, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_D509213C3811","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_866522253978","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-26"}},{"id":"clm_88B7C84F347E","predicate":"shares_outstanding","value":"2,534,023,084 shares","valid_from":"2023-10-31","valid_to":"2024-01-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,534,023,084 shares\", as of 2023-10-31 (until 2024-01-31). Claim clm_88B7C84F347E, https://asof.is/claim/clm_88B7C84F347E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_88B7C84F347E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_95A1CC25AF02","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_65DECC611D27","predicate":"quarterly_revenue","value":"15,962,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,962,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_65DECC611D27, https://asof.is/claim/clm_65DECC611D27, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_65DECC611D27","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8611BE831E10","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_85D17F8D14B8","predicate":"quarterly_research_and_development","value":"3,307,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,307,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_85D17F8D14B8, https://asof.is/claim/clm_85D17F8D14B8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_85D17F8D14B8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD2E2358C2C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_C7767A31CAA9","predicate":"cash_and_equivalents","value":"8,605,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,605,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_C7767A31CAA9, https://asof.is/claim/clm_C7767A31CAA9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_C7767A31CAA9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8B721020A859","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_DBF24049DC48","predicate":"quarterly_net_income","value":"4,745,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,745,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_DBF24049DC48, https://asof.is/claim/clm_DBF24049DC48, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_DBF24049DC48","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_19ED07FEF676","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_EC64212C5C0B","predicate":"total_equity","value":"41,246,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 41,246,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_EC64212C5C0B, https://asof.is/claim/clm_EC64212C5C0B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_EC64212C5C0B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D509213C3811","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_ED1497B9B9A8","predicate":"total_assets","value":"106,727,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,727,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_ED1497B9B9A8, https://asof.is/claim/clm_ED1497B9B9A8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_ED1497B9B9A8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_26E68DAA6E4F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-03"}},{"id":"clm_694106887509","predicate":"shares_outstanding","value":"2,537,521,169 shares","valid_from":"2023-07-31","valid_to":"2023-10-31","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,537,521,169 shares\", as of 2023-07-31 (until 2023-10-31). Claim clm_694106887509, https://asof.is/claim/clm_694106887509, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_694106887509","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_88B7C84F347E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_1A32EEA6D6EC","predicate":"total_assets","value":"104,469,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 104,469,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_1A32EEA6D6EC, https://asof.is/claim/clm_1A32EEA6D6EC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_1A32EEA6D6EC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ED1497B9B9A8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_24E9A9145867","predicate":"total_equity","value":"38,693,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,693,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_24E9A9145867, https://asof.is/claim/clm_24E9A9145867, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_24E9A9145867","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EC64212C5C0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_2AC71CAE212F","predicate":"quarterly_research_and_development","value":"13,321,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 13,321,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_2AC71CAE212F, https://asof.is/claim/clm_2AC71CAE212F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_2AC71CAE212F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_85D17F8D14B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_491D9D1C284F","predicate":"cash_and_equivalents","value":"5,660,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,660,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_491D9D1C284F, https://asof.is/claim/clm_491D9D1C284F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_491D9D1C284F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C7767A31CAA9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_808DE613CD03","predicate":"quarterly_net_income","value":"-5,975,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -5,975,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_808DE613CD03, https://asof.is/claim/clm_808DE613CD03, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_808DE613CD03","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DBF24049DC48","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_CD754CF29134","predicate":"quarterly_revenue","value":"15,035,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,035,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_CD754CF29134, https://asof.is/claim/clm_CD754CF29134, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_CD754CF29134","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_65DECC611D27","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-07"}},{"id":"clm_F79642CF67D5","predicate":"shares_outstanding","value":"2,537,435,954 shares","valid_from":"2023-04-30","valid_to":"2023-07-31","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,537,435,954 shares\", as of 2023-04-30 (until 2023-07-31). Claim clm_F79642CF67D5, https://asof.is/claim/clm_F79642CF67D5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_F79642CF67D5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_694106887509","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_09E404D0868B","predicate":"total_equity","value":"46,834,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,834,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_09E404D0868B, https://asof.is/claim/clm_09E404D0868B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_09E404D0868B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_24E9A9145867","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_353C9EC1DE74","predicate":"quarterly_revenue","value":"14,487,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,487,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_353C9EC1DE74, https://asof.is/claim/clm_353C9EC1DE74, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_353C9EC1DE74","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD754CF29134","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_89BCC3ECADC9","predicate":"total_assets","value":"107,796,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,796,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_89BCC3ECADC9, https://asof.is/claim/clm_89BCC3ECADC9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_89BCC3ECADC9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A32EEA6D6EC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_C41F804AD4A0","predicate":"cash_and_equivalents","value":"9,707,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,707,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_C41F804AD4A0, https://asof.is/claim/clm_C41F804AD4A0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_C41F804AD4A0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_491D9D1C284F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_E5378AE4C74A","predicate":"quarterly_net_income","value":"2,821,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,821,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_E5378AE4C74A, https://asof.is/claim/clm_E5378AE4C74A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_E5378AE4C74A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_808DE613CD03","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_FD249791F8E3","predicate":"quarterly_research_and_development","value":"4,276,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,276,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_FD249791F8E3, https://asof.is/claim/clm_FD249791F8E3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_FD249791F8E3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2AC71CAE212F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2023, filed 2023-05-05"}},{"id":"clm_0DECBB030961","predicate":"shares_outstanding","value":"2,538,592,467 shares","valid_from":"2023-01-31","valid_to":"2023-04-30","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,538,592,467 shares\", as of 2023-01-31 (until 2023-04-30). Claim clm_0DECBB030961, https://asof.is/claim/clm_0DECBB030961, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_0DECBB030961","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F79642CF67D5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_072FE6304876","predicate":"research_and_development","value":"13,548,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 13,548,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_072FE6304876, https://asof.is/claim/clm_072FE6304876, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_072FE6304876","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9F3A2514948A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_3F973E2A6316","predicate":"cash_and_equivalents","value":"12,694,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 12,694,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_3F973E2A6316, https://asof.is/claim/clm_3F973E2A6316, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_3F973E2A6316","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C41F804AD4A0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_5F726FFCF0E7","predicate":"total_assets","value":"109,160,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 109,160,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_5F726FFCF0E7, https://asof.is/claim/clm_5F726FFCF0E7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_5F726FFCF0E7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89BCC3ECADC9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_6570159626A7","predicate":"net_income","value":"14,519,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 14,519,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_6570159626A7, https://asof.is/claim/clm_6570159626A7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_6570159626A7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00E79EEE61A1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_B88AE5A69CF1","predicate":"revenue","value":"59,283,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 59,283,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_B88AE5A69CF1, https://asof.is/claim/clm_B88AE5A69CF1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_B88AE5A69CF1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ABA0DDBCEC64","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_D324B5015E5C","predicate":"total_equity","value":"45,991,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,991,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_D324B5015E5C, https://asof.is/claim/clm_D324B5015E5C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_D324B5015E5C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_09E404D0868B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-24"}},{"id":"clm_ACD78053B586","predicate":"shares_outstanding","value":"2,535,395,974 shares","valid_from":"2022-10-31","valid_to":"2023-01-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,535,395,974 shares\", as of 2022-10-31 (until 2023-01-31). Claim clm_ACD78053B586, https://asof.is/claim/clm_ACD78053B586, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_ACD78053B586","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0DECBB030961","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_0A8F928CFC04","predicate":"quarterly_revenue","value":"14,959,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,959,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_0A8F928CFC04, https://asof.is/claim/clm_0A8F928CFC04, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_0A8F928CFC04","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_353C9EC1DE74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_1C94927C303E","predicate":"quarterly_net_income","value":"3,248,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,248,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_1C94927C303E, https://asof.is/claim/clm_1C94927C303E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_1C94927C303E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E5378AE4C74A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_2E6751788C0B","predicate":"quarterly_research_and_development","value":"4,399,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,399,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_2E6751788C0B, https://asof.is/claim/clm_2E6751788C0B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_2E6751788C0B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FD249791F8E3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_39CF5C3FBCD8","predicate":"total_assets","value":"107,081,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,081,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_39CF5C3FBCD8, https://asof.is/claim/clm_39CF5C3FBCD8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_39CF5C3FBCD8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5F726FFCF0E7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_6012CA07BC66","predicate":"total_equity","value":"44,458,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,458,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_6012CA07BC66, https://asof.is/claim/clm_6012CA07BC66, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_6012CA07BC66","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D324B5015E5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_96DAE1AA412B","predicate":"cash_and_equivalents","value":"11,145,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,145,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_96DAE1AA412B, https://asof.is/claim/clm_96DAE1AA412B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_96DAE1AA412B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3F973E2A6316","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-03"}},{"id":"clm_5509A8889DE0","predicate":"shares_outstanding","value":"2,533,279,845 shares","valid_from":"2022-07-31","valid_to":"2022-10-31","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,533,279,845 shares\", as of 2022-07-31 (until 2022-10-31). Claim clm_5509A8889DE0, https://asof.is/claim/clm_5509A8889DE0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_5509A8889DE0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ACD78053B586","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_1E7926206718","predicate":"total_equity","value":"43,243,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,243,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_1E7926206718, https://asof.is/claim/clm_1E7926206718, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_1E7926206718","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6012CA07BC66","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_604E84C45015","predicate":"quarterly_research_and_development","value":"2,798,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,798,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_604E84C45015, https://asof.is/claim/clm_604E84C45015, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_604E84C45015","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2E6751788C0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_7A280FC574C3","predicate":"cash_and_equivalents","value":"9,675,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,675,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_7A280FC574C3, https://asof.is/claim/clm_7A280FC574C3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_7A280FC574C3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_96DAE1AA412B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_83A31C592A58","predicate":"quarterly_net_income","value":"3,944,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,944,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_83A31C592A58, https://asof.is/claim/clm_83A31C592A58, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_83A31C592A58","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C94927C303E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_B3973D6129B8","predicate":"total_assets","value":"107,095,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,095,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_B3973D6129B8, https://asof.is/claim/clm_B3973D6129B8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_B3973D6129B8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_39CF5C3FBCD8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_C37B63E56958","predicate":"quarterly_revenue","value":"14,593,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,593,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_C37B63E56958, https://asof.is/claim/clm_C37B63E56958, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_C37B63E56958","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0A8F928CFC04","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-08-05"}},{"id":"clm_005E05AF6D5A","predicate":"shares_outstanding","value":"2,528,805,025 shares","valid_from":"2022-04-30","valid_to":"2022-07-31","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,528,805,025 shares\", as of 2022-04-30 (until 2022-07-31). Claim clm_005E05AF6D5A, https://asof.is/claim/clm_005E05AF6D5A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_005E05AF6D5A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5509A8889DE0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_0B9FE3DC3835","predicate":"quarterly_research_and_development","value":"2,576,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,576,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_0B9FE3DC3835, https://asof.is/claim/clm_0B9FE3DC3835, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_0B9FE3DC3835","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_604E84C45015","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_1B94B2C3A373","predicate":"total_equity","value":"40,883,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,883,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_1B94B2C3A373, https://asof.is/claim/clm_1B94B2C3A373, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_1B94B2C3A373","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1E7926206718","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_4630F75144F2","predicate":"total_assets","value":"106,668,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,668,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_4630F75144F2, https://asof.is/claim/clm_4630F75144F2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_4630F75144F2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B3973D6129B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_7ADB25B68A37","predicate":"quarterly_revenue","value":"15,901,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,901,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_7ADB25B68A37, https://asof.is/claim/clm_7ADB25B68A37, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_7ADB25B68A37","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C37B63E56958","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_F618911BB8FA","predicate":"cash_and_equivalents","value":"8,556,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,556,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F618911BB8FA, https://asof.is/claim/clm_F618911BB8FA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_F618911BB8FA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7A280FC574C3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_F9B19A8CB34A","predicate":"quarterly_net_income","value":"4,310,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,310,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F9B19A8CB34A, https://asof.is/claim/clm_F9B19A8CB34A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_F9B19A8CB34A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_83A31C592A58","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-05"}},{"id":"clm_A990AD910616","predicate":"shares_outstanding","value":"2,527,733,606 shares","valid_from":"2022-01-31","valid_to":"2022-04-30","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,527,733,606 shares\", as of 2022-01-31 (until 2022-04-30). Claim clm_A990AD910616, https://asof.is/claim/clm_A990AD910616, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_A990AD910616","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_005E05AF6D5A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_0ED12C79C31B","predicate":"total_assets","value":"105,694,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,694,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_0ED12C79C31B, https://asof.is/claim/clm_0ED12C79C31B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_0ED12C79C31B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4630F75144F2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_0FA531F72A09","predicate":"total_equity","value":"38,184,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,184,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_0FA531F72A09, https://asof.is/claim/clm_0FA531F72A09, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_0FA531F72A09","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1B94B2C3A373","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_1B82FCD1E106","predicate":"revenue","value":"48,704,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 48,704,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1B82FCD1E106, https://asof.is/claim/clm_1B82FCD1E106, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_1B82FCD1E106","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B88AE5A69CF1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_230B3C47EC80","predicate":"cash_and_equivalents","value":"8,096,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,096,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_230B3C47EC80, https://asof.is/claim/clm_230B3C47EC80, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_230B3C47EC80","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F618911BB8FA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_52D1E12C9A04","predicate":"research_and_development","value":"12,245,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 12,245,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_52D1E12C9A04, https://asof.is/claim/clm_52D1E12C9A04, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_52D1E12C9A04","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_072FE6304876","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_D12FFF001055","predicate":"net_income","value":"13,049,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 13,049,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_D12FFF001055, https://asof.is/claim/clm_D12FFF001055, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_D12FFF001055","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6570159626A7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-25"}},{"id":"clm_034CAAEA4834","predicate":"shares_outstanding","value":"2,525,943,936 shares","valid_from":"2021-10-31","valid_to":"2022-01-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,525,943,936 shares\", as of 2021-10-31 (until 2022-01-31). Claim clm_034CAAEA4834, https://asof.is/claim/clm_034CAAEA4834, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_034CAAEA4834","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A990AD910616","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_3A29303F7FB7","predicate":"cash_and_equivalents","value":"10,016,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 10,016,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_3A29303F7FB7, https://asof.is/claim/clm_3A29303F7FB7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_3A29303F7FB7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_230B3C47EC80","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_6271F68058A2","predicate":"quarterly_research_and_development","value":"2,445,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,445,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_6271F68058A2, https://asof.is/claim/clm_6271F68058A2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_6271F68058A2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0B9FE3DC3835","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_7124FBE763AC","predicate":"quarterly_net_income","value":"4,567,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,567,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_7124FBE763AC, https://asof.is/claim/clm_7124FBE763AC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_7124FBE763AC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F9B19A8CB34A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_7FAB128C3F5D","predicate":"total_equity","value":"35,794,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 35,794,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_7FAB128C3F5D, https://asof.is/claim/clm_7FAB128C3F5D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_7FAB128C3F5D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0FA531F72A09","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_8FBD1A9DB37D","predicate":"total_assets","value":"93,494,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 93,494,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_8FBD1A9DB37D, https://asof.is/claim/clm_8FBD1A9DB37D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_8FBD1A9DB37D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0ED12C79C31B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_B112868B77BC","predicate":"quarterly_revenue","value":"13,154,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 13,154,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_B112868B77BC, https://asof.is/claim/clm_B112868B77BC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_B112868B77BC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7ADB25B68A37","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-11-05"}},{"id":"clm_7D9AD895C751","predicate":"shares_outstanding","value":"2,531,374,696 shares","valid_from":"2021-07-31","valid_to":"2021-10-31","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,531,374,696 shares\", as of 2021-07-31 (until 2021-10-31). Claim clm_7D9AD895C751, https://asof.is/claim/clm_7D9AD895C751, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_7D9AD895C751","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_034CAAEA4834","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_0517E31C3FEB","predicate":"quarterly_net_income","value":"1,545,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,545,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0517E31C3FEB, https://asof.is/claim/clm_0517E31C3FEB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_0517E31C3FEB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7124FBE763AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_0AFE389E5C48","predicate":"total_assets","value":"90,688,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,688,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0AFE389E5C48, https://asof.is/claim/clm_0AFE389E5C48, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_0AFE389E5C48","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8FBD1A9DB37D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_6520ACD0ED9A","predicate":"total_equity","value":"33,294,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 33,294,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_6520ACD0ED9A, https://asof.is/claim/clm_6520ACD0ED9A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_6520ACD0ED9A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7FAB128C3F5D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_80ED88D5B228","predicate":"cash_and_equivalents","value":"8,575,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,575,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_80ED88D5B228, https://asof.is/claim/clm_80ED88D5B228, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_80ED88D5B228","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3A29303F7FB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_C3C0E7554FA8","predicate":"quarterly_research_and_development","value":"4,321,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,321,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_C3C0E7554FA8, https://asof.is/claim/clm_C3C0E7554FA8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_C3C0E7554FA8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6271F68058A2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_C9956D0CFD23","predicate":"quarterly_revenue","value":"11,402,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,402,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_C9956D0CFD23, https://asof.is/claim/clm_C9956D0CFD23, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_C9956D0CFD23","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B112868B77BC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-08-09"}},{"id":"clm_02F25E967F12","predicate":"shares_outstanding","value":"2,532,058,364 shares","valid_from":"2021-04-30","valid_to":"2021-07-31","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,058,364 shares\", as of 2021-04-30 (until 2021-07-31). Claim clm_02F25E967F12, https://asof.is/claim/clm_02F25E967F12, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_02F25E967F12","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7D9AD895C751","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_1D93C5758916","predicate":"total_assets","value":"90,847,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,847,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_1D93C5758916, https://asof.is/claim/clm_1D93C5758916, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_1D93C5758916","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0AFE389E5C48","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_29418B6878C2","predicate":"total_equity","value":"26,945,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,945,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_29418B6878C2, https://asof.is/claim/clm_29418B6878C2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_29418B6878C2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6520ACD0ED9A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_2B42EB43141D","predicate":"quarterly_revenue","value":"12,080,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,080,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_2B42EB43141D, https://asof.is/claim/clm_2B42EB43141D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_2B42EB43141D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C9956D0CFD23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_2DA98D07113A","predicate":"cash_and_equivalents","value":"6,981,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,981,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_2DA98D07113A, https://asof.is/claim/clm_2DA98D07113A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_2DA98D07113A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_80ED88D5B228","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_602E83B5A23B","predicate":"quarterly_research_and_development","value":"2,465,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,465,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_602E83B5A23B, https://asof.is/claim/clm_602E83B5A23B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_602E83B5A23B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C3C0E7554FA8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_64B45488298B","predicate":"quarterly_net_income","value":"3,179,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,179,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_64B45488298B, https://asof.is/claim/clm_64B45488298B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_64B45488298B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0517E31C3FEB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-05"}},{"id":"clm_DB50492A0D5C","predicate":"shares_outstanding","value":"2,530,315,668 shares","valid_from":"2021-01-31","valid_to":"2021-04-30","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,530,315,668 shares\", as of 2021-01-31 (until 2021-04-30). Claim clm_DB50492A0D5C, https://asof.is/claim/clm_DB50492A0D5C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_DB50492A0D5C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02F25E967F12","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_2D92122CFA57","predicate":"total_assets","value":"91,588,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 91,588,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_2D92122CFA57, https://asof.is/claim/clm_2D92122CFA57, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_2D92122CFA57","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D93C5758916","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_3479D27E9553","predicate":"cash_and_equivalents","value":"8,062,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,062,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_3479D27E9553, https://asof.is/claim/clm_3479D27E9553, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_3479D27E9553","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2DA98D07113A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_6003F5963D12","predicate":"research_and_development","value":"13,558,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 13,558,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_6003F5963D12, https://asof.is/claim/clm_6003F5963D12, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_6003F5963D12","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_52D1E12C9A04","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_B923437A977E","predicate":"total_equity","value":"25,317,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 25,317,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_B923437A977E, https://asof.is/claim/clm_B923437A977E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_B923437A977E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29418B6878C2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_F41E55DA096F","predicate":"revenue","value":"47,994,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 47,994,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F41E55DA096F, https://asof.is/claim/clm_F41E55DA096F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_F41E55DA096F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1B82FCD1E106","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_F81DAFAD73AE","predicate":"net_income","value":"7,067,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 7,067,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F81DAFAD73AE, https://asof.is/claim/clm_F81DAFAD73AE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_F81DAFAD73AE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D12FFF001055","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-25T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-25"}},{"id":"clm_19A0DB5C39B2","predicate":"shares_outstanding","value":"2,530,034,437 shares","valid_from":"2020-10-31","valid_to":"2021-01-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,530,034,437 shares\", as of 2020-10-31 (until 2021-01-31). Claim clm_19A0DB5C39B2, https://asof.is/claim/clm_19A0DB5C39B2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_19A0DB5C39B2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DB50492A0D5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_2214A1ACEDDD","predicate":"total_equity","value":"29,186,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 29,186,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_2214A1ACEDDD, https://asof.is/claim/clm_2214A1ACEDDD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_2214A1ACEDDD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B923437A977E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_3D89E44DB40E","predicate":"cash_and_equivalents","value":"7,356,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,356,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3D89E44DB40E, https://asof.is/claim/clm_3D89E44DB40E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_3D89E44DB40E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3479D27E9553","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_5C1E46793168","predicate":"quarterly_revenue","value":"12,551,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,551,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_5C1E46793168, https://asof.is/claim/clm_5C1E46793168, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_5C1E46793168","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2B42EB43141D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_601363BB78C5","predicate":"quarterly_research_and_development","value":"3,390,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,390,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_601363BB78C5, https://asof.is/claim/clm_601363BB78C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_601363BB78C5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_602E83B5A23B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_B8D35EEE2364","predicate":"total_assets","value":"89,800,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 89,800,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_B8D35EEE2364, https://asof.is/claim/clm_B8D35EEE2364, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_B8D35EEE2364","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2D92122CFA57","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_F4D24DFDC05F","predicate":"quarterly_net_income","value":"2,941,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,941,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_F4D24DFDC05F, https://asof.is/claim/clm_F4D24DFDC05F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_F4D24DFDC05F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_64B45488298B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-05"}},{"id":"clm_26BCDBE0EE1C","predicate":"shares_outstanding","value":"2,529,241,070 shares","valid_from":"2020-07-31","valid_to":"2020-10-31","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,529,241,070 shares\", as of 2020-07-31 (until 2020-10-31). Claim clm_26BCDBE0EE1C, https://asof.is/claim/clm_26BCDBE0EE1C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_26BCDBE0EE1C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_19A0DB5C39B2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_418AA1D3C2FF","predicate":"total_equity","value":"27,642,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,642,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_418AA1D3C2FF, https://asof.is/claim/clm_418AA1D3C2FF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_418AA1D3C2FF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2214A1ACEDDD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_84481BCEF2DA","predicate":"total_assets","value":"90,615,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,615,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_84481BCEF2DA, https://asof.is/claim/clm_84481BCEF2DA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_84481BCEF2DA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B8D35EEE2364","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_AFC6EDCC90D8","predicate":"quarterly_revenue","value":"10,872,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,872,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_AFC6EDCC90D8, https://asof.is/claim/clm_AFC6EDCC90D8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_AFC6EDCC90D8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5C1E46793168","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_F0C3055A26FF","predicate":"cash_and_equivalents","value":"11,103,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,103,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F0C3055A26FF, https://asof.is/claim/clm_F0C3055A26FF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F0C3055A26FF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3D89E44DB40E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_F21AC6FA6FAB","predicate":"quarterly_research_and_development","value":"2,123,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,123,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F21AC6FA6FAB, https://asof.is/claim/clm_F21AC6FA6FAB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F21AC6FA6FAB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_601363BB78C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_F7B34F85A744","predicate":"quarterly_net_income","value":"3,002,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,002,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F7B34F85A744, https://asof.is/claim/clm_F7B34F85A744, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F7B34F85A744","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4D24DFDC05F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_A5759D744830","predicate":"shares_outstanding","value":"2,524,101,191 shares","valid_from":"2020-04-30","valid_to":"2020-07-31","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,524,101,191 shares\", as of 2020-04-30 (until 2020-07-31). Claim clm_A5759D744830, https://asof.is/claim/clm_A5759D744830, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_A5759D744830","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_26BCDBE0EE1C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_1A9DF101A4EB","predicate":"quarterly_net_income","value":"3,219,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,219,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_1A9DF101A4EB, https://asof.is/claim/clm_1A9DF101A4EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_1A9DF101A4EB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F7B34F85A744","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_2A9BC3DD361F","predicate":"total_assets","value":"84,913,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 84,913,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_2A9BC3DD361F, https://asof.is/claim/clm_2A9BC3DD361F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_2A9BC3DD361F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_84481BCEF2DA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_2F02734188EA","predicate":"cash_and_equivalents","value":"7,425,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,425,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_2F02734188EA, https://asof.is/claim/clm_2F02734188EA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_2F02734188EA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F0C3055A26FF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_5596F1B23FD3","predicate":"quarterly_research_and_development","value":"2,209,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,209,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_5596F1B23FD3, https://asof.is/claim/clm_5596F1B23FD3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_5596F1B23FD3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F21AC6FA6FAB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_8230E6A696F5","predicate":"total_equity","value":"26,205,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,205,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_8230E6A696F5, https://asof.is/claim/clm_8230E6A696F5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_8230E6A696F5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_418AA1D3C2FF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_E554AD8078D3","predicate":"quarterly_revenue","value":"12,057,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,057,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_E554AD8078D3, https://asof.is/claim/clm_E554AD8078D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_E554AD8078D3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AFC6EDCC90D8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_B554111539E4","predicate":"shares_outstanding","value":"2,536,268,760 shares","valid_from":"2020-01-31","valid_to":"2020-04-30","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,536,268,760 shares\", as of 2020-01-31 (until 2020-04-30). Claim clm_B554111539E4, https://asof.is/claim/clm_B554111539E4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_B554111539E4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5759D744830","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_029900C42A81","predicate":"total_assets","value":"84,397,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 84,397,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_029900C42A81, https://asof.is/claim/clm_029900C42A81, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_029900C42A81","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2A9BC3DD361F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_51169445BDC3","predicate":"total_equity","value":"25,907,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 25,907,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_51169445BDC3, https://asof.is/claim/clm_51169445BDC3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_51169445BDC3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8230E6A696F5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_72B03D5517FF","predicate":"revenue","value":"46,840,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 46,840,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_72B03D5517FF, https://asof.is/claim/clm_72B03D5517FF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_72B03D5517FF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F41E55DA096F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_97E52B2371D0","predicate":"net_income","value":"9,843,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 9,843,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_97E52B2371D0, https://asof.is/claim/clm_97E52B2371D0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_97E52B2371D0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F81DAFAD73AE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_D5BC12D2484C","predicate":"research_and_development","value":"9,872,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 9,872,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_D5BC12D2484C, https://asof.is/claim/clm_D5BC12D2484C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_D5BC12D2484C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6003F5963D12","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_F75263B1D61F","predicate":"cash_and_equivalents","value":"9,676,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,676,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_F75263B1D61F, https://asof.is/claim/clm_F75263B1D61F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_F75263B1D61F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2F02734188EA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-26"}},{"id":"clm_EC29FB8F343C","predicate":"shares_outstanding","value":"2,545,984,142 shares","valid_from":"2019-10-31","valid_to":"2020-01-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,545,984,142 shares\", as of 2019-10-31 (until 2020-01-31). Claim clm_EC29FB8F343C, https://asof.is/claim/clm_EC29FB8F343C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_EC29FB8F343C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B554111539E4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_13B057D601E9","predicate":"cash_and_equivalents","value":"7,869,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,869,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_13B057D601E9, https://asof.is/claim/clm_13B057D601E9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_13B057D601E9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F75263B1D61F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_3AE77590962D","predicate":"quarterly_revenue","value":"12,397,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,397,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_3AE77590962D, https://asof.is/claim/clm_3AE77590962D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_3AE77590962D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E554AD8078D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_7CE9BE85C914","predicate":"total_equity","value":"26,838,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,838,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_7CE9BE85C914, https://asof.is/claim/clm_7CE9BE85C914, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_7CE9BE85C914","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_51169445BDC3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_B868BDC6CD31","predicate":"quarterly_research_and_development","value":"3,204,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,204,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_B868BDC6CD31, https://asof.is/claim/clm_B868BDC6CD31, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_B868BDC6CD31","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5596F1B23FD3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_C49B13FDDF3A","predicate":"quarterly_net_income","value":"1,901,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,901,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_C49B13FDDF3A, https://asof.is/claim/clm_C49B13FDDF3A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_C49B13FDDF3A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A9DF101A4EB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_DF0DF5E31A2D","predicate":"total_assets","value":"83,331,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 83,331,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_DF0DF5E31A2D, https://asof.is/claim/clm_DF0DF5E31A2D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_DF0DF5E31A2D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_029900C42A81","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-05"}},{"id":"clm_24A63371969B","predicate":"shares_outstanding","value":"2,560,374,643 shares","valid_from":"2019-07-31","valid_to":"2019-10-31","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,560,374,643 shares\", as of 2019-07-31 (until 2019-10-31). Claim clm_24A63371969B, https://asof.is/claim/clm_24A63371969B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_24A63371969B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EC29FB8F343C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_07EDDEDB6853","predicate":"total_assets","value":"83,965,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 83,965,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_07EDDEDB6853, https://asof.is/claim/clm_07EDDEDB6853, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_07EDDEDB6853","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DF0DF5E31A2D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_104F474E5C73","predicate":"quarterly_net_income","value":"2,670,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,670,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_104F474E5C73, https://asof.is/claim/clm_104F474E5C73, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_104F474E5C73","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C49B13FDDF3A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_25A17B48A15F","predicate":"quarterly_revenue","value":"11,760,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,760,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_25A17B48A15F, https://asof.is/claim/clm_25A17B48A15F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_25A17B48A15F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3AE77590962D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_3F564403AA3B","predicate":"total_equity","value":"27,635,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,635,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_3F564403AA3B, https://asof.is/claim/clm_3F564403AA3B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_3F564403AA3B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7CE9BE85C914","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_EB2F3D5D01EC","predicate":"cash_and_equivalents","value":"6,659,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,659,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_EB2F3D5D01EC, https://asof.is/claim/clm_EB2F3D5D01EC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_EB2F3D5D01EC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_13B057D601E9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_FE9AB4A6BF09","predicate":"quarterly_research_and_development","value":"2,189,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,189,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_FE9AB4A6BF09, https://asof.is/claim/clm_FE9AB4A6BF09, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_FE9AB4A6BF09","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B868BDC6CD31","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-08-06"}},{"id":"clm_45D07EF51ABE","predicate":"shares_outstanding","value":"2,574,644,410 shares","valid_from":"2019-04-30","valid_to":"2019-07-31","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,574,644,410 shares\", as of 2019-04-30 (until 2019-07-31). Claim clm_45D07EF51ABE, https://asof.is/claim/clm_45D07EF51ABE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_45D07EF51ABE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_24A63371969B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_296C5FD003C5","predicate":"total_assets","value":"82,354,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 82,354,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_296C5FD003C5, https://asof.is/claim/clm_296C5FD003C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_296C5FD003C5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_07EDDEDB6853","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_3122AF3523E0","predicate":"quarterly_research_and_development","value":"1,931,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,931,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_3122AF3523E0, https://asof.is/claim/clm_3122AF3523E0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_3122AF3523E0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FE9AB4A6BF09","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_7CB401BF90C0","predicate":"total_equity","value":"27,539,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,539,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_7CB401BF90C0, https://asof.is/claim/clm_7CB401BF90C0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_7CB401BF90C0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3F564403AA3B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_800327091376","predicate":"quarterly_revenue","value":"10,816,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,816,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_800327091376, https://asof.is/claim/clm_800327091376, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_800327091376","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_25A17B48A15F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_BA62E6A9ABE6","predicate":"cash_and_equivalents","value":"8,076,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,076,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_BA62E6A9ABE6, https://asof.is/claim/clm_BA62E6A9ABE6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_BA62E6A9ABE6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EB2F3D5D01EC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_F508DB33EABE","predicate":"quarterly_net_income","value":"2,915,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,915,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F508DB33EABE, https://asof.is/claim/clm_F508DB33EABE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_F508DB33EABE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_104F474E5C73","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_9AEDFCF6FFF1","predicate":"shares_outstanding","value":"2,581,220,308 shares","valid_from":"2019-01-31","valid_to":"2019-04-30","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,581,220,308 shares\", as of 2019-01-31 (until 2019-04-30). Claim clm_9AEDFCF6FFF1, https://asof.is/claim/clm_9AEDFCF6FFF1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_9AEDFCF6FFF1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_45D07EF51ABE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_6CE3449E9C0D","predicate":"total_assets","value":"82,637,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 82,637,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6CE3449E9C0D, https://asof.is/claim/clm_6CE3449E9C0D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_6CE3449E9C0D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_296C5FD003C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_781231FF91DC","predicate":"research_and_development","value":"9,752,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 9,752,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_781231FF91DC, https://asof.is/claim/clm_781231FF91DC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_781231FF91DC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D5BC12D2484C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_829CCD9C74BC","predicate":"revenue","value":"42,294,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 42,294,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_829CCD9C74BC, https://asof.is/claim/clm_829CCD9C74BC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_829CCD9C74BC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72B03D5517FF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_C4B47494D086","predicate":"cash_and_equivalents","value":"7,965,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,965,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_C4B47494D086, https://asof.is/claim/clm_C4B47494D086, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_C4B47494D086","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA62E6A9ABE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_D1FFB154F0E4","predicate":"net_income","value":"6,220,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,220,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_D1FFB154F0E4, https://asof.is/claim/clm_D1FFB154F0E4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_D1FFB154F0E4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_97E52B2371D0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_E57111F73208","predicate":"total_equity","value":"26,701,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,701,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_E57111F73208, https://asof.is/claim/clm_E57111F73208, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_E57111F73208","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7CB401BF90C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_F1CB002B7759","predicate":"shares_outstanding","value":"2,600,376,500 shares","valid_from":"2018-10-31","valid_to":"2019-01-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,600,376,500 shares\", as of 2018-10-31 (until 2019-01-31). Claim clm_F1CB002B7759, https://asof.is/claim/clm_F1CB002B7759, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_F1CB002B7759","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9AEDFCF6FFF1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_2724E09F4094","predicate":"quarterly_research_and_development","value":"2,068,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,068,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_2724E09F4094, https://asof.is/claim/clm_2724E09F4094, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_2724E09F4094","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3122AF3523E0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_59E105928DAD","predicate":"total_equity","value":"32,422,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 32,422,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_59E105928DAD, https://asof.is/claim/clm_59E105928DAD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_59E105928DAD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E57111F73208","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_B3CC449D09A5","predicate":"cash_and_equivalents","value":"7,826,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,826,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_B3CC449D09A5, https://asof.is/claim/clm_B3CC449D09A5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_B3CC449D09A5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C4B47494D086","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_E5380D65707D","predicate":"quarterly_revenue","value":"10,794,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,794,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_E5380D65707D, https://asof.is/claim/clm_E5380D65707D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_E5380D65707D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_800327091376","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_F3A459B65CBF","predicate":"total_assets","value":"85,130,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 85,130,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_F3A459B65CBF, https://asof.is/claim/clm_F3A459B65CBF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_F3A459B65CBF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6CE3449E9C0D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_FC96B547649A","predicate":"quarterly_net_income","value":"1,950,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,950,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_FC96B547649A, https://asof.is/claim/clm_FC96B547649A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_FC96B547649A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F508DB33EABE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_0629D11AC216","predicate":"shares_outstanding","value":"2,659,525,311 shares","valid_from":"2018-07-31","valid_to":"2018-10-31","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,659,525,311 shares\", as of 2018-07-31 (until 2018-10-31). Claim clm_0629D11AC216, https://asof.is/claim/clm_0629D11AC216, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_0629D11AC216","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F1CB002B7759","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_00D624D3F6C6","predicate":"total_assets","value":"85,040,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 85,040,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_00D624D3F6C6, https://asof.is/claim/clm_00D624D3F6C6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_00D624D3F6C6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F3A459B65CBF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_AAA255A07687","predicate":"cash_and_equivalents","value":"5,310,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,310,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_AAA255A07687, https://asof.is/claim/clm_AAA255A07687, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_AAA255A07687","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B3CC449D09A5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_B18491AB2F19","predicate":"quarterly_net_income","value":"1,707,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,707,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_B18491AB2F19, https://asof.is/claim/clm_B18491AB2F19, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_B18491AB2F19","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FC96B547649A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_BF9BD7C5474F","predicate":"total_equity","value":"32,529,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 32,529,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_BF9BD7C5474F, https://asof.is/claim/clm_BF9BD7C5474F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_BF9BD7C5474F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59E105928DAD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_EAA01F078C81","predicate":"quarterly_revenue","value":"10,465,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,465,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_EAA01F078C81, https://asof.is/claim/clm_EAA01F078C81, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_EAA01F078C81","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E5380D65707D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_FD39BFA827F7","predicate":"quarterly_research_and_development","value":"2,274,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,274,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FD39BFA827F7, https://asof.is/claim/clm_FD39BFA827F7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_FD39BFA827F7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2724E09F4094","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_5CB49AA3F905","predicate":"shares_outstanding","value":"2,690,303,898 shares","valid_from":"2018-04-30","valid_to":"2018-07-31","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,690,303,898 shares\", as of 2018-04-30 (until 2018-07-31). Claim clm_5CB49AA3F905, https://asof.is/claim/clm_5CB49AA3F905, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_5CB49AA3F905","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0629D11AC216","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_600C98D7D769","predicate":"total_equity","value":"33,668,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 33,668,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_600C98D7D769, https://asof.is/claim/clm_600C98D7D769, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_600C98D7D769","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BF9BD7C5474F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_72F018D1F42C","predicate":"quarterly_research_and_development","value":"3,196,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,196,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_72F018D1F42C, https://asof.is/claim/clm_72F018D1F42C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_72F018D1F42C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FD39BFA827F7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_B05C96267A31","predicate":"total_assets","value":"86,041,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 86,041,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_B05C96267A31, https://asof.is/claim/clm_B05C96267A31, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_B05C96267A31","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00D624D3F6C6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_C199DABE1F23","predicate":"cash_and_equivalents","value":"4,483,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,483,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_C199DABE1F23, https://asof.is/claim/clm_C199DABE1F23, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_C199DABE1F23","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AAA255A07687","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_D25BE24533C1","predicate":"quarterly_net_income","value":"736,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 736,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_D25BE24533C1, https://asof.is/claim/clm_D25BE24533C1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_D25BE24533C1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B18491AB2F19","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-08"}},{"id":"clm_E8AC27AFE10B","predicate":"quarterly_revenue","value":"10,037,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,037,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_E8AC27AFE10B, https://asof.is/claim/clm_E8AC27AFE10B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_E8AC27AFE10B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EAA01F078C81","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-08"}},{"id":"clm_EE7BE5F78BEA","predicate":"shares_outstanding","value":"2,696,190,502 shares","valid_from":"2018-01-31","valid_to":"2018-04-30","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,696,190,502 shares\", as of 2018-01-31 (until 2018-04-30). Claim clm_EE7BE5F78BEA, https://asof.is/claim/clm_EE7BE5F78BEA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_EE7BE5F78BEA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5CB49AA3F905","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_1145C38DDEF9","predicate":"revenue","value":"40,122,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 40,122,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_1145C38DDEF9, https://asof.is/claim/clm_1145C38DDEF9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_1145C38DDEF9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_829CCD9C74BC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_232F37648DD2","predicate":"cash_and_equivalents","value":"6,092,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,092,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_232F37648DD2, https://asof.is/claim/clm_232F37648DD2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_232F37648DD2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C199DABE1F23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_2BFBBD91DD20","predicate":"total_assets","value":"87,872,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 87,872,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_2BFBBD91DD20, https://asof.is/claim/clm_2BFBBD91DD20, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_2BFBBD91DD20","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B05C96267A31","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_BC24AF78EFCB","predicate":"total_equity","value":"34,336,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 34,336,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_BC24AF78EFCB, https://asof.is/claim/clm_BC24AF78EFCB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_BC24AF78EFCB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_600C98D7D769","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_C217AE3D4BB6","predicate":"research_and_development","value":"10,208,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,208,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_C217AE3D4BB6, https://asof.is/claim/clm_C217AE3D4BB6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_C217AE3D4BB6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_781231FF91DC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_C317F9A41D65","predicate":"net_income","value":"2,394,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 2,394,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_C317F9A41D65, https://asof.is/claim/clm_C317F9A41D65, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_C317F9A41D65","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D1FFB154F0E4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-27"}},{"id":"clm_9F2CDB05F1E9","predicate":"shares_outstanding","value":"2,724,436,835 shares","valid_from":"2017-10-31","valid_to":"2018-01-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,724,436,835 shares\", as of 2017-10-31 (until 2018-01-31). Claim clm_9F2CDB05F1E9, https://asof.is/claim/clm_9F2CDB05F1E9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_9F2CDB05F1E9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE7BE5F78BEA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_207F5C0875B9","predicate":"total_equity","value":"38,248,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,248,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_207F5C0875B9, https://asof.is/claim/clm_207F5C0875B9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_207F5C0875B9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BC24AF78EFCB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_393DB4682B31","predicate":"quarterly_research_and_development","value":"4,383,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,383,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_393DB4682B31, https://asof.is/claim/clm_393DB4682B31, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_393DB4682B31","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72F018D1F42C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_B00F52FDD238","predicate":"quarterly_net_income","value":"-56,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -56,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_B00F52FDD238, https://asof.is/claim/clm_B00F52FDD238, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_B00F52FDD238","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D25BE24533C1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_B47A627983F0","predicate":"cash_and_equivalents","value":"7,901,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,901,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_B47A627983F0, https://asof.is/claim/clm_B47A627983F0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_B47A627983F0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_232F37648DD2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_C6F722C9950C","predicate":"total_assets","value":"91,676,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 91,676,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_C6F722C9950C, https://asof.is/claim/clm_C6F722C9950C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_C6F722C9950C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2BFBBD91DD20","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-07"}},{"id":"clm_CE4B75CB7BCE","predicate":"quarterly_revenue","value":"10,325,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,325,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_CE4B75CB7BCE, https://asof.is/claim/clm_CE4B75CB7BCE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_CE4B75CB7BCE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E8AC27AFE10B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_EEE6786E9E9E","predicate":"shares_outstanding","value":"2,727,354,340 shares","valid_from":"2017-07-31","valid_to":"2017-10-31","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,727,354,340 shares\", as of 2017-07-31 (until 2017-10-31). Claim clm_EEE6786E9E9E, https://asof.is/claim/clm_EEE6786E9E9E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_EEE6786E9E9E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9F2CDB05F1E9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_02E1EC40EBB1","predicate":"quarterly_revenue","value":"9,930,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 9,930,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_02E1EC40EBB1, https://asof.is/claim/clm_02E1EC40EBB1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_02E1EC40EBB1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CE4B75CB7BCE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-07"}},{"id":"clm_069AC1ED0F10","predicate":"cash_and_equivalents","value":"7,786,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,786,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_069AC1ED0F10, https://asof.is/claim/clm_069AC1ED0F10, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_069AC1ED0F10","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B47A627983F0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_3B507E46CC5D","predicate":"quarterly_research_and_development","value":"1,749,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,749,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_3B507E46CC5D, https://asof.is/claim/clm_3B507E46CC5D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_3B507E46CC5D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_393DB4682B31","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_4DB34C3A4F05","predicate":"quarterly_net_income","value":"1,946,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,946,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_4DB34C3A4F05, https://asof.is/claim/clm_4DB34C3A4F05, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_4DB34C3A4F05","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B00F52FDD238","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_868E075D6D61","predicate":"total_equity","value":"39,463,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 39,463,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_868E075D6D61, https://asof.is/claim/clm_868E075D6D61, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_868E075D6D61","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_207F5C0875B9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_8BFD8488B3A5","predicate":"total_assets","value":"92,804,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 92,804,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_8BFD8488B3A5, https://asof.is/claim/clm_8BFD8488B3A5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_8BFD8488B3A5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C6F722C9950C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_17404A75E250","predicate":"shares_outstanding","value":"2,735,164,510 shares","valid_from":"2017-04-30","valid_to":"2017-07-31","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,735,164,510 shares\", as of 2017-04-30 (until 2017-07-31). Claim clm_17404A75E250, https://asof.is/claim/clm_17404A75E250, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_17404A75E250","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EEE6786E9E9E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_0CA94408597F","predicate":"quarterly_net_income","value":"1,551,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,551,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_0CA94408597F, https://asof.is/claim/clm_0CA94408597F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_0CA94408597F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4DB34C3A4F05","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_372309F7322C","predicate":"cash_and_equivalents","value":"11,708,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,708,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_372309F7322C, https://asof.is/claim/clm_372309F7322C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_372309F7322C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_069AC1ED0F10","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_8BB7754D3964","predicate":"total_equity","value":"39,837,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 39,837,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_8BB7754D3964, https://asof.is/claim/clm_8BB7754D3964, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_8BB7754D3964","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_868E075D6D61","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_92759280B530","predicate":"total_assets","value":"96,561,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 96,561,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_92759280B530, https://asof.is/claim/clm_92759280B530, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_92759280B530","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8BFD8488B3A5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_E6943054D4C9","predicate":"quarterly_research_and_development","value":"1,796,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,796,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E6943054D4C9, https://asof.is/claim/clm_E6943054D4C9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_E6943054D4C9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3B507E46CC5D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2017, filed 2017-05-09"}},{"id":"clm_3E4686F1C38B","predicate":"shares_outstanding","value":"2,745,571,067 shares","valid_from":"2017-01-31","valid_to":"2017-04-30","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,745,571,067 shares\", as of 2017-01-31 (until 2017-04-30). Claim clm_3E4686F1C38B, https://asof.is/claim/clm_3E4686F1C38B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_3E4686F1C38B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_17404A75E250","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_296D7E29A85C","predicate":"cash_and_equivalents","value":"6,515,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,515,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_296D7E29A85C, https://asof.is/claim/clm_296D7E29A85C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_296D7E29A85C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_372309F7322C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_2F97411688D4","predicate":"net_income","value":"3,920,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 3,920,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_2F97411688D4, https://asof.is/claim/clm_2F97411688D4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_2F97411688D4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C317F9A41D65","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_8B7063543990","predicate":"research_and_development","value":"10,124,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,124,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_8B7063543990, https://asof.is/claim/clm_8B7063543990, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_8B7063543990","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C217AE3D4BB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_9C0CF77D801C","predicate":"total_assets","value":"95,377,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 95,377,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_9C0CF77D801C, https://asof.is/claim/clm_9C0CF77D801C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_9C0CF77D801C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_92759280B530","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_B3973E2ADB22","predicate":"revenue","value":"39,807,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 39,807,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_B3973E2ADB22, https://asof.is/claim/clm_B3973E2ADB22, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_B3973E2ADB22","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1145C38DDEF9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"id":"clm_F4558D2EB9F0","predicate":"total_equity","value":"40,088,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,088,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_F4558D2EB9F0, https://asof.is/claim/clm_F4558D2EB9F0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_F4558D2EB9F0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8BB7754D3964","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-28"}},{"id":"clm_9225D2BB085B","predicate":"shares_outstanding","value":"2,757,137,517 shares","valid_from":"2016-10-31","valid_to":"2017-01-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,757,137,517 shares\", as of 2016-10-31 (until 2017-01-31). Claim clm_9225D2BB085B, https://asof.is/claim/clm_9225D2BB085B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_9225D2BB085B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3E4686F1C38B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_437CAECBFA51","predicate":"cash_and_equivalents","value":"7,907,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,907,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_437CAECBFA51, https://asof.is/claim/clm_437CAECBFA51, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_437CAECBFA51","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_296D7E29A85C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_8C42F3B5F24C","predicate":"quarterly_net_income","value":"2,184,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,184,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_8C42F3B5F24C, https://asof.is/claim/clm_8C42F3B5F24C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_8C42F3B5F24C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0CA94408597F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_96D16DB08BF3","predicate":"total_equity","value":"43,744,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,744,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_96D16DB08BF3, https://asof.is/claim/clm_96D16DB08BF3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_96D16DB08BF3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4558D2EB9F0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_CEE60B020EE0","predicate":"total_assets","value":"98,335,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,335,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_CEE60B020EE0, https://asof.is/claim/clm_CEE60B020EE0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_CEE60B020EE0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9C0CF77D801C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_E2DBCCAAB311","predicate":"quarterly_research_and_development","value":"1,664,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,664,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_E2DBCCAAB311, https://asof.is/claim/clm_E2DBCCAAB311, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_E2DBCCAAB311","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E6943054D4C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2016, filed 2016-11-07"}},{"id":"clm_42D5BA4A587B","predicate":"shares_outstanding","value":"2,765,208,203 shares","valid_from":"2016-07-31","valid_to":"2016-10-31","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,765,208,203 shares\", as of 2016-07-31 (until 2016-10-31). Claim clm_42D5BA4A587B, https://asof.is/claim/clm_42D5BA4A587B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_42D5BA4A587B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9225D2BB085B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_4FDF2F5B4857","predicate":"quarterly_research_and_development","value":"2,151,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,151,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_4FDF2F5B4857, https://asof.is/claim/clm_4FDF2F5B4857, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_4FDF2F5B4857","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E2DBCCAAB311","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_86A8CB1D7187","predicate":"total_equity","value":"43,357,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,357,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_86A8CB1D7187, https://asof.is/claim/clm_86A8CB1D7187, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_86A8CB1D7187","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_96D16DB08BF3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_A89A271BF7E1","predicate":"cash_and_equivalents","value":"6,608,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,608,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_A89A271BF7E1, https://asof.is/claim/clm_A89A271BF7E1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_A89A271BF7E1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_437CAECBFA51","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_C2D709880E62","predicate":"quarterly_net_income","value":"1,205,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,205,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_C2D709880E62, https://asof.is/claim/clm_C2D709880E62, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_C2D709880E62","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8C42F3B5F24C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_CFF0D674C75A","predicate":"total_assets","value":"96,475,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 96,475,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_CFF0D674C75A, https://asof.is/claim/clm_CFF0D674C75A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_CFF0D674C75A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CEE60B020EE0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-08"}},{"id":"clm_76492752CBD6","predicate":"shares_outstanding","value":"2,768,025,348 shares","valid_from":"2016-04-30","valid_to":"2016-07-31","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,768,025,348 shares\", as of 2016-04-30 (until 2016-07-31). Claim clm_76492752CBD6, https://asof.is/claim/clm_76492752CBD6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_76492752CBD6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_42D5BA4A587B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_288991751ADB","predicate":"total_assets","value":"98,755,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,755,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_288991751ADB, https://asof.is/claim/clm_288991751ADB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_288991751ADB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CFF0D674C75A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_825172ED4990","predicate":"cash_and_equivalents","value":"9,716,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,716,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_825172ED4990, https://asof.is/claim/clm_825172ED4990, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_825172ED4990","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A89A271BF7E1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_85649A72C697","predicate":"quarterly_net_income","value":"1,125,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,125,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_85649A72C697, https://asof.is/claim/clm_85649A72C697, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_85649A72C697","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C2D709880E62","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_D488C57B0FAA","predicate":"quarterly_research_and_development","value":"1,659,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,659,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_D488C57B0FAA, https://asof.is/claim/clm_D488C57B0FAA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_D488C57B0FAA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4FDF2F5B4857","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_D96A931644FC","predicate":"total_equity","value":"43,806,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,806,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_D96A931644FC, https://asof.is/claim/clm_D96A931644FC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_D96A931644FC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_86A8CB1D7187","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-05-09"}},{"id":"clm_3AABB9FFA15E","predicate":"shares_outstanding","value":"2,775,258,591 shares","valid_from":"2016-01-31","valid_to":"2016-04-30","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,775,258,591 shares\", as of 2016-01-31 (until 2016-04-30). Claim clm_3AABB9FFA15E, https://asof.is/claim/clm_3AABB9FFA15E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_3AABB9FFA15E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_76492752CBD6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_5192469BE119","predicate":"net_income","value":"4,442,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 4,442,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_5192469BE119, https://asof.is/claim/clm_5192469BE119, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_5192469BE119","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2F97411688D4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_7BDCD397A17D","predicate":"cash_and_equivalents","value":"8,524,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,524,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_7BDCD397A17D, https://asof.is/claim/clm_7BDCD397A17D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_7BDCD397A17D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_825172ED4990","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_D52E6DA72BE9","predicate":"research_and_development","value":"6,704,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 6,704,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_D52E6DA72BE9, https://asof.is/claim/clm_D52E6DA72BE9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_D52E6DA72BE9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8B7063543990","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_F89730A7CEBD","predicate":"total_equity","value":"44,676,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,676,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_F89730A7CEBD, https://asof.is/claim/clm_F89730A7CEBD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_F89730A7CEBD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D96A931644FC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_FEF2D6BB7989","predicate":"total_assets","value":"101,779,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,779,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_FEF2D6BB7989, https://asof.is/claim/clm_FEF2D6BB7989, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_FEF2D6BB7989","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_288991751ADB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-26"}},{"id":"clm_1C1225C23E40","predicate":"shares_outstanding","value":"2,793,543,137 shares","valid_from":"2015-10-31","valid_to":"2016-01-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,793,543,137 shares\", as of 2015-10-31 (until 2016-01-31). Claim clm_1C1225C23E40, https://asof.is/claim/clm_1C1225C23E40, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_1C1225C23E40","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3AABB9FFA15E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_15359FB5299B","predicate":"total_equity","value":"45,587,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,587,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_15359FB5299B, https://asof.is/claim/clm_15359FB5299B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_15359FB5299B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F89730A7CEBD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_59257E5213FA","predicate":"cash_and_equivalents","value":"7,548,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,548,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_59257E5213FA, https://asof.is/claim/clm_59257E5213FA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_59257E5213FA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7BDCD397A17D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_A47DE2B24AF2","predicate":"total_assets","value":"101,232,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,232,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_A47DE2B24AF2, https://asof.is/claim/clm_A47DE2B24AF2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_A47DE2B24AF2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FEF2D6BB7989","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_AC2912FEAAED","predicate":"quarterly_research_and_development","value":"1,500,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,500,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_AC2912FEAAED, https://asof.is/claim/clm_AC2912FEAAED, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_AC2912FEAAED","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D488C57B0FAA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_CDDC90397241","predicate":"quarterly_net_income","value":"1,826,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,826,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_CDDC90397241, https://asof.is/claim/clm_CDDC90397241, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_CDDC90397241","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_85649A72C697","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-11-05"}},{"id":"clm_53616B87641B","predicate":"shares_outstanding","value":"2,816,635,020 shares","valid_from":"2015-07-31","valid_to":"2015-10-31","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,816,635,020 shares\", as of 2015-07-31 (until 2015-10-31). Claim clm_53616B87641B, https://asof.is/claim/clm_53616B87641B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_53616B87641B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C1225C23E40","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_19CFD7F8FB0B","predicate":"quarterly_research_and_development","value":"1,670,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,670,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_19CFD7F8FB0B, https://asof.is/claim/clm_19CFD7F8FB0B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_19CFD7F8FB0B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AC2912FEAAED","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_1A67A4E05244","predicate":"total_assets","value":"102,582,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 102,582,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_1A67A4E05244, https://asof.is/claim/clm_1A67A4E05244, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_1A67A4E05244","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A47DE2B24AF2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_39A0C18651A0","predicate":"total_equity","value":"46,448,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,448,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_39A0C18651A0, https://asof.is/claim/clm_39A0C18651A0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_39A0C18651A0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_15359FB5299B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_580CDBD2CB5C","predicate":"quarterly_net_income","value":"687,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 687,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_580CDBD2CB5C, https://asof.is/claim/clm_580CDBD2CB5C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_580CDBD2CB5C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CDDC90397241","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_6919D2A6E878","predicate":"cash_and_equivalents","value":"6,922,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,922,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_6919D2A6E878, https://asof.is/claim/clm_6919D2A6E878, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_6919D2A6E878","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59257E5213FA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-08-06"}},{"id":"clm_14F0931A2C29","predicate":"shares_outstanding","value":"2,825,221,749 shares","valid_from":"2015-04-30","valid_to":"2015-07-31","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,825,221,749 shares\", as of 2015-04-30 (until 2015-07-31). Claim clm_14F0931A2C29, https://asof.is/claim/clm_14F0931A2C29, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_14F0931A2C29","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53616B87641B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_22FB10ADCE7F","predicate":"total_equity","value":"47,765,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,765,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_22FB10ADCE7F, https://asof.is/claim/clm_22FB10ADCE7F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_22FB10ADCE7F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_39A0C18651A0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_3053C11D0C03","predicate":"total_assets","value":"108,345,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 108,345,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_3053C11D0C03, https://asof.is/claim/clm_3053C11D0C03, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_3053C11D0C03","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A67A4E05244","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_49402CF1E6AD","predicate":"cash_and_equivalents","value":"7,980,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,980,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_49402CF1E6AD, https://asof.is/claim/clm_49402CF1E6AD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_49402CF1E6AD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6919D2A6E878","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_B147AAA7DA5F","predicate":"quarterly_research_and_development","value":"1,737,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,737,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_B147AAA7DA5F, https://asof.is/claim/clm_B147AAA7DA5F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_B147AAA7DA5F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_19CFD7F8FB0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_EA4D3DE6DF4C","predicate":"quarterly_net_income","value":"953,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 953,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_EA4D3DE6DF4C, https://asof.is/claim/clm_EA4D3DE6DF4C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_EA4D3DE6DF4C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_580CDBD2CB5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-07"}},{"id":"clm_3B9D279D2011","predicate":"shares_outstanding","value":"2,838,192,933 shares","valid_from":"2015-01-31","valid_to":"2015-04-30","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,838,192,933 shares\", as of 2015-01-31 (until 2015-04-30). Claim clm_3B9D279D2011, https://asof.is/claim/clm_3B9D279D2011, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_3B9D279D2011","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_14F0931A2C29","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_0E5197A56A4E","predicate":"total_equity","value":"48,647,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,647,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_0E5197A56A4E, https://asof.is/claim/clm_0E5197A56A4E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_0E5197A56A4E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_22FB10ADCE7F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_18E23DA639C2","predicate":"total_assets","value":"98,335,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,335,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_18E23DA639C2, https://asof.is/claim/clm_18E23DA639C2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_18E23DA639C2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3053C11D0C03","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_480EA42C5F46","predicate":"net_income","value":"11,920,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 11,920,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_480EA42C5F46, https://asof.is/claim/clm_480EA42C5F46, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_480EA42C5F46","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5192469BE119","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_7B46759F0E5E","predicate":"research_and_development","value":"7,180,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 7,180,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_7B46759F0E5E, https://asof.is/claim/clm_7B46759F0E5E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_7B46759F0E5E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D52E6DA72BE9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_89F2FC090FA9","predicate":"cash_and_equivalents","value":"7,441,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,441,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_89F2FC090FA9, https://asof.is/claim/clm_89F2FC090FA9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_89F2FC090FA9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49402CF1E6AD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-27"}},{"id":"clm_F28C55B6A7FE","predicate":"shares_outstanding","value":"2,850,873,371 shares","valid_from":"2014-10-31","valid_to":"2015-01-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,850,873,371 shares\", as of 2014-10-31 (until 2015-01-31). Claim clm_F28C55B6A7FE, https://asof.is/claim/clm_F28C55B6A7FE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_F28C55B6A7FE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3B9D279D2011","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_3A6CAF21DAAA","predicate":"total_assets","value":"101,808,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,808,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_3A6CAF21DAAA, https://asof.is/claim/clm_3A6CAF21DAAA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_3A6CAF21DAAA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18E23DA639C2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_49837366C97C","predicate":"quarterly_research_and_development","value":"1,659,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,659,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_49837366C97C, https://asof.is/claim/clm_49837366C97C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_49837366C97C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B147AAA7DA5F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_62E7AB824032","predicate":"cash_and_equivalents","value":"11,370,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,370,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_62E7AB824032, https://asof.is/claim/clm_62E7AB824032, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_62E7AB824032","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89F2FC090FA9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_693AD5707AD7","predicate":"quarterly_net_income","value":"895,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 895,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_693AD5707AD7, https://asof.is/claim/clm_693AD5707AD7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_693AD5707AD7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EA4D3DE6DF4C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_89371CE7088F","predicate":"total_equity","value":"45,224,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,224,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_89371CE7088F, https://asof.is/claim/clm_89371CE7088F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_89371CE7088F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0E5197A56A4E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-10"}},{"id":"clm_5853AEBD7F61","predicate":"shares_outstanding","value":"2,884,632,033 shares","valid_from":"2014-07-31","valid_to":"2014-10-31","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,884,632,033 shares\", as of 2014-07-31 (until 2014-10-31). Claim clm_5853AEBD7F61, https://asof.is/claim/clm_5853AEBD7F61, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_5853AEBD7F61","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F28C55B6A7FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_911F877CC3E3","predicate":"quarterly_research_and_development","value":"1,664,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,664,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_911F877CC3E3, https://asof.is/claim/clm_911F877CC3E3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_911F877CC3E3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49837366C97C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_94E54F01B864","predicate":"total_equity","value":"48,358,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,358,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_94E54F01B864, https://asof.is/claim/clm_94E54F01B864, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_94E54F01B864","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89371CE7088F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_C51678D27969","predicate":"cash_and_equivalents","value":"9,743,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,743,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_C51678D27969, https://asof.is/claim/clm_C51678D27969, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_C51678D27969","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_62E7AB824032","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_C6D2D1307E74","predicate":"total_assets","value":"97,860,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 97,860,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_C6D2D1307E74, https://asof.is/claim/clm_C6D2D1307E74, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_C6D2D1307E74","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3A6CAF21DAAA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_F00D1BA511E6","predicate":"quarterly_net_income","value":"2,004,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,004,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_F00D1BA511E6, https://asof.is/claim/clm_F00D1BA511E6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_F00D1BA511E6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_693AD5707AD7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-07"}},{"id":"clm_E265F2EB9492","predicate":"shares_outstanding","value":"2,922,376,244 shares","valid_from":"2014-04-30","valid_to":"2014-07-31","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,922,376,244 shares\", as of 2014-04-30 (until 2014-07-31). Claim clm_E265F2EB9492, https://asof.is/claim/clm_E265F2EB9492, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_E265F2EB9492","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5853AEBD7F61","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_05F2BFB4125E","predicate":"quarterly_research_and_development","value":"1,574,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,574,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_05F2BFB4125E, https://asof.is/claim/clm_05F2BFB4125E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_05F2BFB4125E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_911F877CC3E3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_210F97389E0B","predicate":"cash_and_equivalents","value":"15,828,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,828,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_210F97389E0B, https://asof.is/claim/clm_210F97389E0B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_210F97389E0B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C51678D27969","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_8BA31BB74F0A","predicate":"total_equity","value":"49,975,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 49,975,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_8BA31BB74F0A, https://asof.is/claim/clm_8BA31BB74F0A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_8BA31BB74F0A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_94E54F01B864","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_A09FA8993177","predicate":"total_assets","value":"108,460,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 108,460,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_A09FA8993177, https://asof.is/claim/clm_A09FA8993177, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_A09FA8993177","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C6D2D1307E74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_E212531659DD","predicate":"quarterly_net_income","value":"1,705,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,705,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_E212531659DD, https://asof.is/claim/clm_E212531659DD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_E212531659DD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F00D1BA511E6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-08"}},{"id":"clm_2416DCFDB05C","predicate":"shares_outstanding","value":"2,940,622,461 shares","valid_from":"2014-01-31","valid_to":"2014-04-30","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,940,622,461 shares\", as of 2014-01-31 (until 2014-04-30). Claim clm_2416DCFDB05C, https://asof.is/claim/clm_2416DCFDB05C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_2416DCFDB05C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E265F2EB9492","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_18DE3EDE6596","predicate":"total_assets","value":"105,645,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,645,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_18DE3EDE6596, https://asof.is/claim/clm_18DE3EDE6596, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_18DE3EDE6596","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A09FA8993177","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_229317196120","predicate":"research_and_development","value":"7,503,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 7,503,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_229317196120, https://asof.is/claim/clm_229317196120, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_229317196120","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7B46759F0E5E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_A0F5C187BF3E","predicate":"total_equity","value":"49,765,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 49,765,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_A0F5C187BF3E, https://asof.is/claim/clm_A0F5C187BF3E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_A0F5C187BF3E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8BA31BB74F0A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_A5D39D3E54E7","predicate":"cash_and_equivalents","value":"15,621,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,621,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_A5D39D3E54E7, https://asof.is/claim/clm_A5D39D3E54E7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_A5D39D3E54E7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_210F97389E0B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_E27BC8C8DD77","predicate":"net_income","value":"4,404,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 4,404,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_E27BC8C8DD77, https://asof.is/claim/clm_E27BC8C8DD77, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_E27BC8C8DD77","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_480EA42C5F46","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-27T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-02-27"}},{"id":"clm_5DBCAF2D77B1","predicate":"shares_outstanding","value":"2,921,928,875 shares","valid_from":"2013-10-31","valid_to":"2014-01-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,921,928,875 shares\", as of 2013-10-31 (until 2014-01-31). Claim clm_5DBCAF2D77B1, https://asof.is/claim/clm_5DBCAF2D77B1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_5DBCAF2D77B1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2416DCFDB05C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_1EC02EAE4AB2","predicate":"total_equity","value":"47,419,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,419,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_1EC02EAE4AB2, https://asof.is/claim/clm_1EC02EAE4AB2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_1EC02EAE4AB2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A0F5C187BF3E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_9EF1364229B5","predicate":"total_assets","value":"106,419,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,419,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_9EF1364229B5, https://asof.is/claim/clm_9EF1364229B5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_9EF1364229B5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_18DE3EDE6596","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_A29E493EA927","predicate":"cash_and_equivalents","value":"14,090,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,090,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_A29E493EA927, https://asof.is/claim/clm_A29E493EA927, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_A29E493EA927","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A5D39D3E54E7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_E3E08B5ED822","predicate":"quarterly_net_income","value":"1,124,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,124,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_E3E08B5ED822, https://asof.is/claim/clm_E3E08B5ED822, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_E3E08B5ED822","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E212531659DD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_E70B4951C373","predicate":"quarterly_research_and_development","value":"1,660,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,660,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_E70B4951C373, https://asof.is/claim/clm_E70B4951C373, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_E70B4951C373","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_05F2BFB4125E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2013, filed 2013-11-07"}},{"id":"clm_A36CCC65D836","predicate":"shares_outstanding","value":"2,926,375,532 shares","valid_from":"2013-07-31","valid_to":"2013-10-31","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,926,375,532 shares\", as of 2013-07-31 (until 2013-10-31). Claim clm_A36CCC65D836, https://asof.is/claim/clm_A36CCC65D836, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_A36CCC65D836","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5DBCAF2D77B1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_494220063F74","predicate":"cash_and_equivalents","value":"15,090,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,090,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_494220063F74, https://asof.is/claim/clm_494220063F74, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_494220063F74","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A29E493EA927","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_866963D28A7C","predicate":"quarterly_research_and_development","value":"2,101,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,101,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_866963D28A7C, https://asof.is/claim/clm_866963D28A7C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_866963D28A7C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E70B4951C373","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_8979652BD6C4","predicate":"total_equity","value":"47,500,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,500,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_8979652BD6C4, https://asof.is/claim/clm_8979652BD6C4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_8979652BD6C4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1EC02EAE4AB2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_9DA08D3D51BF","predicate":"quarterly_net_income","value":"906,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 906,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_9DA08D3D51BF, https://asof.is/claim/clm_9DA08D3D51BF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_9DA08D3D51BF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E3E08B5ED822","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_DCC0FF436A6C","predicate":"total_assets","value":"106,876,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,876,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_DCC0FF436A6C, https://asof.is/claim/clm_DCC0FF436A6C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_DCC0FF436A6C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9EF1364229B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-07"}},{"id":"clm_11D540F5CFF2","predicate":"shares_outstanding","value":"3,019,611,844 shares","valid_from":"2013-04-30","valid_to":"2013-07-31","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,019,611,844 shares\", as of 2013-04-30 (until 2013-07-31). Claim clm_11D540F5CFF2, https://asof.is/claim/clm_11D540F5CFF2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_11D540F5CFF2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A36CCC65D836","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_283B3063FEFA","predicate":"quarterly_net_income","value":"1,593,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,593,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_283B3063FEFA, https://asof.is/claim/clm_283B3063FEFA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_283B3063FEFA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DA08D3D51BF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_90FA1C2EE047","predicate":"cash_and_equivalents","value":"13,024,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,024,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_90FA1C2EE047, https://asof.is/claim/clm_90FA1C2EE047, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_90FA1C2EE047","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_494220063F74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_911FFD783AD9","predicate":"quarterly_research_and_development","value":"1,907,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,907,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_911FFD783AD9, https://asof.is/claim/clm_911FFD783AD9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_911FFD783AD9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_866963D28A7C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_9DD1E2DA6948","predicate":"total_equity","value":"53,029,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 53,029,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_9DD1E2DA6948, https://asof.is/claim/clm_9DD1E2DA6948, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_9DD1E2DA6948","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8979652BD6C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_AB6793F263FE","predicate":"total_assets","value":"106,200,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,200,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_AB6793F263FE, https://asof.is/claim/clm_AB6793F263FE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_AB6793F263FE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DCC0FF436A6C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-09"}},{"id":"clm_8D39CFAFEB7C","predicate":"shares_outstanding","value":"3,022,367,538 shares","valid_from":"2013-01-31","valid_to":"2013-04-30","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,022,367,538 shares\", as of 2013-01-31 (until 2013-04-30). Claim clm_8D39CFAFEB7C, https://asof.is/claim/clm_8D39CFAFEB7C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_8D39CFAFEB7C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_11D540F5CFF2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_54A1A6CA4C2B","predicate":"research_and_development","value":"8,168,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 8,168,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_54A1A6CA4C2B, https://asof.is/claim/clm_54A1A6CA4C2B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_54A1A6CA4C2B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_229317196120","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_61010F0E4CF3","predicate":"cash_and_equivalents","value":"13,451,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,451,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_61010F0E4CF3, https://asof.is/claim/clm_61010F0E4CF3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_61010F0E4CF3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_90FA1C2EE047","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_6A173E23DD15","predicate":"net_income","value":"6,168,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,168,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_6A173E23DD15, https://asof.is/claim/clm_6A173E23DD15, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_6A173E23DD15","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E27BC8C8DD77","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_74DBDC2276F6","predicate":"total_assets","value":"106,132,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,132,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_74DBDC2276F6, https://asof.is/claim/clm_74DBDC2276F6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_74DBDC2276F6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AB6793F263FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_974390ADF164","predicate":"total_equity","value":"53,020,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 53,020,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_974390ADF164, https://asof.is/claim/clm_974390ADF164, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_974390ADF164","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DD1E2DA6948","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2012, filed 2013-02-28"}},{"id":"clm_850BEDD17E38","predicate":"shares_outstanding","value":"3,040,071,937 shares","valid_from":"2012-10-31","valid_to":"2013-01-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,040,071,937 shares\", as of 2012-10-31 (until 2013-01-31). Claim clm_850BEDD17E38, https://asof.is/claim/clm_850BEDD17E38, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_850BEDD17E38","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8D39CFAFEB7C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_286B9F63C75F","predicate":"quarterly_net_income","value":"1,729,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,729,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_286B9F63C75F, https://asof.is/claim/clm_286B9F63C75F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_286B9F63C75F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_283B3063FEFA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_395E0D5CE587","predicate":"cash_and_equivalents","value":"17,360,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 17,360,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_395E0D5CE587, https://asof.is/claim/clm_395E0D5CE587, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_395E0D5CE587","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_61010F0E4CF3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_70F74D2F16D3","predicate":"total_equity","value":"55,747,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,747,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_70F74D2F16D3, https://asof.is/claim/clm_70F74D2F16D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_70F74D2F16D3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_974390ADF164","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_C41FF0FA4FEA","predicate":"quarterly_research_and_development","value":"1,918,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,918,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_C41FF0FA4FEA, https://asof.is/claim/clm_C41FF0FA4FEA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_C41FF0FA4FEA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_911FFD783AD9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_CA202DF46EB3","predicate":"total_assets","value":"106,301,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,301,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_CA202DF46EB3, https://asof.is/claim/clm_CA202DF46EB3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_CA202DF46EB3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_74DBDC2276F6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-09"}},{"id":"clm_79BF421588A8","predicate":"shares_outstanding","value":"3,045,632,274 shares","valid_from":"2012-07-31","valid_to":"2012-10-31","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,045,632,274 shares\", as of 2012-07-31 (until 2012-10-31). Claim clm_79BF421588A8, https://asof.is/claim/clm_79BF421588A8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_79BF421588A8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_850BEDD17E38","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_13272BAF15D6","predicate":"quarterly_net_income","value":"1,793,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,793,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_13272BAF15D6, https://asof.is/claim/clm_13272BAF15D6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_13272BAF15D6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_286B9F63C75F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_5897CB0342BB","predicate":"quarterly_research_and_development","value":"2,165,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,165,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_5897CB0342BB, https://asof.is/claim/clm_5897CB0342BB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_5897CB0342BB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C41FF0FA4FEA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_6D6AE389AC7E","predicate":"total_equity","value":"55,194,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,194,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_6D6AE389AC7E, https://asof.is/claim/clm_6D6AE389AC7E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_6D6AE389AC7E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_70F74D2F16D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_7AC0686FEEC4","predicate":"total_assets","value":"105,525,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,525,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_7AC0686FEEC4, https://asof.is/claim/clm_7AC0686FEEC4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_7AC0686FEEC4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA202DF46EB3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_7FF9FF3EAA65","predicate":"cash_and_equivalents","value":"16,752,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 16,752,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_7FF9FF3EAA65, https://asof.is/claim/clm_7FF9FF3EAA65, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_7FF9FF3EAA65","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_395E0D5CE587","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_5053AEF3E520","predicate":"shares_outstanding","value":"3,041,564,692 shares","valid_from":"2012-04-30","valid_to":"2012-07-31","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,041,564,692 shares\", as of 2012-04-30 (until 2012-07-31). Claim clm_5053AEF3E520, https://asof.is/claim/clm_5053AEF3E520, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_5053AEF3E520","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_79BF421588A8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_1BEC26313598","predicate":"total_equity","value":"54,860,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,860,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_1BEC26313598, https://asof.is/claim/clm_1BEC26313598, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_1BEC26313598","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6D6AE389AC7E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_5152EB930B57","predicate":"cash_and_equivalents","value":"14,656,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,656,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_5152EB930B57, https://asof.is/claim/clm_5152EB930B57, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_5152EB930B57","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7FF9FF3EAA65","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_95A2A8BB89F6","predicate":"quarterly_research_and_development","value":"1,862,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,862,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_95A2A8BB89F6, https://asof.is/claim/clm_95A2A8BB89F6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_95A2A8BB89F6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5897CB0342BB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_AD058299EEE7","predicate":"quarterly_net_income","value":"1,738,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,738,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_AD058299EEE7, https://asof.is/claim/clm_AD058299EEE7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_AD058299EEE7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_13272BAF15D6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_F0A7F5A9AE14","predicate":"total_assets","value":"105,509,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,509,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_F0A7F5A9AE14, https://asof.is/claim/clm_F0A7F5A9AE14, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_F0A7F5A9AE14","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7AC0686FEEC4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-08"}},{"id":"clm_FC3671A94172","predicate":"shares_outstanding","value":"3,044,008,396 shares","valid_from":"2012-01-31","valid_to":"2012-04-30","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,044,008,396 shares\", as of 2012-01-31 (until 2012-04-30). Claim clm_FC3671A94172, https://asof.is/claim/clm_FC3671A94172, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_FC3671A94172","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5053AEF3E520","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_1A15195A46D3","predicate":"total_equity","value":"54,517,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,517,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_1A15195A46D3, https://asof.is/claim/clm_1A15195A46D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_1A15195A46D3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1BEC26313598","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_253292471BFE","predicate":"cash_and_equivalents","value":"13,531,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,531,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_253292471BFE, https://asof.is/claim/clm_253292471BFE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_253292471BFE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5152EB930B57","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_42F08F87AE73","predicate":"total_assets","value":"105,128,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,128,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_42F08F87AE73, https://asof.is/claim/clm_42F08F87AE73, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_42F08F87AE73","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F0A7F5A9AE14","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_6551D4B7258D","predicate":"research_and_development","value":"8,467,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 8,467,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_6551D4B7258D, https://asof.is/claim/clm_6551D4B7258D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_6551D4B7258D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54A1A6CA4C2B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_7A9570A80387","predicate":"net_income","value":"6,272,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,272,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_7A9570A80387, https://asof.is/claim/clm_7A9570A80387, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_7A9570A80387","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6A173E23DD15","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2011, filed 2012-02-28"}},{"id":"clm_C5688CBF2599","predicate":"shares_outstanding","value":"3,047,921,407 shares","valid_from":"2011-10-31","valid_to":"2012-01-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,047,921,407 shares\", as of 2011-10-31 (until 2012-01-31). Claim clm_C5688CBF2599, https://asof.is/claim/clm_C5688CBF2599, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_C5688CBF2599","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FC3671A94172","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_1F7AAAEEBAA8","predicate":"quarterly_research_and_development","value":"1,954,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,954,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_1F7AAAEEBAA8, https://asof.is/claim/clm_1F7AAAEEBAA8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_1F7AAAEEBAA8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_95A2A8BB89F6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_963AB2E89F87","predicate":"quarterly_net_income","value":"1,692,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,692,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_963AB2E89F87, https://asof.is/claim/clm_963AB2E89F87, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_963AB2E89F87","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD058299EEE7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_D995E1344989","predicate":"total_assets","value":"106,534,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,534,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_D995E1344989, https://asof.is/claim/clm_D995E1344989, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_D995E1344989","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_42F08F87AE73","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_E7890C41F190","predicate":"total_equity","value":"55,140,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,140,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_E7890C41F190, https://asof.is/claim/clm_E7890C41F190, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_E7890C41F190","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A15195A46D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_F02B729073B0","predicate":"cash_and_equivalents","value":"14,253,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,253,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_F02B729073B0, https://asof.is/claim/clm_F02B729073B0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_F02B729073B0","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_253292471BFE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-08"}},{"id":"clm_BA6238CBFDB6","predicate":"shares_outstanding","value":"3,080,796,992 shares","valid_from":"2011-07-29","valid_to":"2011-10-31","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,080,796,992 shares\", as of 2011-07-29 (until 2011-10-31). Claim clm_BA6238CBFDB6, https://asof.is/claim/clm_BA6238CBFDB6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_BA6238CBFDB6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C5688CBF2599","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_1C2CAA0EE3AB","predicate":"quarterly_research_and_development","value":"1,936,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,936,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_1C2CAA0EE3AB, https://asof.is/claim/clm_1C2CAA0EE3AB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_1C2CAA0EE3AB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1F7AAAEEBAA8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_33FE8193CAC6","predicate":"total_equity","value":"55,496,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,496,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_33FE8193CAC6, https://asof.is/claim/clm_33FE8193CAC6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_33FE8193CAC6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E7890C41F190","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_4193E1EB977C","predicate":"quarterly_net_income","value":"2,024,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,024,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_4193E1EB977C, https://asof.is/claim/clm_4193E1EB977C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_4193E1EB977C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_963AB2E89F87","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_7C24258D5116","predicate":"cash_and_equivalents","value":"12,342,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 12,342,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_7C24258D5116, https://asof.is/claim/clm_7C24258D5116, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_7C24258D5116","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F02B729073B0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_FA9DB79A8B0C","predicate":"total_assets","value":"106,195,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,195,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_FA9DB79A8B0C, https://asof.is/claim/clm_FA9DB79A8B0C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_FA9DB79A8B0C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D995E1344989","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-08"}},{"id":"clm_6E96761DDE05","predicate":"shares_outstanding","value":"3,086,584,896 shares","valid_from":"2011-04-29","valid_to":"2011-07-29","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,086,584,896 shares\", as of 2011-04-29 (until 2011-07-29). Claim clm_6E96761DDE05, https://asof.is/claim/clm_6E96761DDE05, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_6E96761DDE05","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA6238CBFDB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_138E9F8C2AD6","predicate":"cash_and_equivalents","value":"11,695,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,695,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_138E9F8C2AD6, https://asof.is/claim/clm_138E9F8C2AD6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_138E9F8C2AD6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7C24258D5116","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_3319A0215022","predicate":"quarterly_research_and_development","value":"2,158,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,158,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_3319A0215022, https://asof.is/claim/clm_3319A0215022, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_3319A0215022","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C2CAA0EE3AB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_3B74FEDC21AF","predicate":"total_assets","value":"105,865,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,865,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_3B74FEDC21AF, https://asof.is/claim/clm_3B74FEDC21AF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_3B74FEDC21AF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA9DB79A8B0C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_65A1060B45EF","predicate":"quarterly_net_income","value":"1,043,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,043,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_65A1060B45EF, https://asof.is/claim/clm_65A1060B45EF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_65A1060B45EF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4193E1EB977C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_A3FD179A993F","predicate":"total_equity","value":"54,384,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,384,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_A3FD179A993F, https://asof.is/claim/clm_A3FD179A993F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_A3FD179A993F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_33FE8193CAC6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_DD04D89D847D","predicate":"quarterly_revenue","value":"11,580,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2017-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,580,000,000 United States dollar\", as of 2011-03-31 (until 2017-06-30). Claim clm_DD04D89D847D, https://asof.is/claim/clm_DD04D89D847D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_DD04D89D847D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02E1EC40EBB1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2011, filed 2011-05-09"}},{"id":"clm_9BF1CD5FE3CA","predicate":"shares_outstanding","value":"3,083,080,697 shares","valid_from":"2011-01-31","valid_to":"2011-04-29","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,083,080,697 shares\", as of 2011-01-31 (until 2011-04-29). Claim clm_9BF1CD5FE3CA, https://asof.is/claim/clm_9BF1CD5FE3CA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_9BF1CD5FE3CA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E96761DDE05","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_254D7953C206","predicate":"total_equity","value":"54,376,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,376,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_254D7953C206, https://asof.is/claim/clm_254D7953C206, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_254D7953C206","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A3FD179A993F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_2BED9DF30C40","predicate":"cash_and_equivalents","value":"10,900,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 10,900,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_2BED9DF30C40, https://asof.is/claim/clm_2BED9DF30C40, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_2BED9DF30C40","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_138E9F8C2AD6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_39AC82F2B073","predicate":"net_income","value":"861,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 861,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_39AC82F2B073, https://asof.is/claim/clm_39AC82F2B073, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_39AC82F2B073","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7A9570A80387","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_6B2D64844C16","predicate":"revenue","value":"45,987,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2016-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 45,987,000,000 United States dollar\", as of 2010-12-31 (until 2016-12-31). Claim clm_6B2D64844C16, https://asof.is/claim/clm_6B2D64844C16, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_6B2D64844C16","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B3973E2ADB22","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_6FC7FC088DC8","predicate":"total_assets","value":"105,781,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,781,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_6FC7FC088DC8, https://asof.is/claim/clm_6FC7FC088DC8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_6FC7FC088DC8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3B74FEDC21AF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_DAC5122F3F04","predicate":"research_and_development","value":"10,991,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,991,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_DAC5122F3F04, https://asof.is/claim/clm_DAC5122F3F04, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_DAC5122F3F04","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6551D4B7258D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-28"}},{"id":"clm_84A1426313AA","predicate":"shares_outstanding","value":"3,080,880,847 shares","valid_from":"2010-10-29","valid_to":"2011-01-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,080,880,847 shares\", as of 2010-10-29 (until 2011-01-31). Claim clm_84A1426313AA, https://asof.is/claim/clm_84A1426313AA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_84A1426313AA","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9BF1CD5FE3CA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_12C2D8877AC1","predicate":"quarterly_net_income","value":"341,600,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 341,600,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_12C2D8877AC1, https://asof.is/claim/clm_12C2D8877AC1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_12C2D8877AC1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_65A1060B45EF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_8F41253963FE","predicate":"total_assets","value":"107,840,100,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,840,100,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_8F41253963FE, https://asof.is/claim/clm_8F41253963FE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_8F41253963FE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6FC7FC088DC8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_A0E18FFDE026","predicate":"total_equity","value":"55,592,800,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,592,800,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_A0E18FFDE026, https://asof.is/claim/clm_A0E18FFDE026, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_A0E18FFDE026","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_254D7953C206","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_CAF2B5061F55","predicate":"quarterly_revenue","value":"11,124,900,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,124,900,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_CAF2B5061F55, https://asof.is/claim/clm_CAF2B5061F55, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CAF2B5061F55","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD04D89D847D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_CB134DA21407","predicate":"quarterly_research_and_development","value":"2,296,400,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,296,400,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_CB134DA21407, https://asof.is/claim/clm_CB134DA21407, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CB134DA21407","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3319A0215022","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_CED915E12E43","predicate":"cash_and_equivalents","value":"9,874,400,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,874,400,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_CED915E12E43, https://asof.is/claim/clm_CED915E12E43, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CED915E12E43","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2BED9DF30C40","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_E46983415AD5","predicate":"shares_outstanding","value":"3,073,593,302 shares","valid_from":"2010-07-30","valid_to":"2010-10-29","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,073,593,302 shares\", as of 2010-07-30 (until 2010-10-29). Claim clm_E46983415AD5, https://asof.is/claim/clm_E46983415AD5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_E46983415AD5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_84A1426313AA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_0BF16A111DB1","predicate":"cash_and_equivalents","value":"8,665,600,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,665,600,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_0BF16A111DB1, https://asof.is/claim/clm_0BF16A111DB1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_0BF16A111DB1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CED915E12E43","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_6F134AACBD0F","predicate":"total_assets","value":"106,170,500,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,170,500,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_6F134AACBD0F, https://asof.is/claim/clm_6F134AACBD0F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_6F134AACBD0F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8F41253963FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_8425BCAEBDE4","predicate":"quarterly_research_and_development","value":"2,150,900,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,150,900,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_8425BCAEBDE4, https://asof.is/claim/clm_8425BCAEBDE4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_8425BCAEBDE4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CB134DA21407","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_87DCBE668D46","predicate":"quarterly_net_income","value":"752,400,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 752,400,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_87DCBE668D46, https://asof.is/claim/clm_87DCBE668D46, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_87DCBE668D46","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_12C2D8877AC1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_D746F14C7469","predicate":"quarterly_revenue","value":"11,346,300,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,346,300,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_D746F14C7469, https://asof.is/claim/clm_D746F14C7469, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_D746F14C7469","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CAF2B5061F55","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_FB8799A4CF05","predicate":"total_equity","value":"55,231,700,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,231,700,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_FB8799A4CF05, https://asof.is/claim/clm_FB8799A4CF05, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_FB8799A4CF05","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A0E18FFDE026","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_6BFEF753A9AF","predicate":"shares_outstanding","value":"3,118,252,244 shares","valid_from":"2010-04-30","valid_to":"2010-07-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,118,252,244 shares\", as of 2010-04-30 (until 2010-07-30). Claim clm_6BFEF753A9AF, https://asof.is/claim/clm_6BFEF753A9AF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_6BFEF753A9AF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E46983415AD5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_49575E9AC377","predicate":"quarterly_research_and_development","value":"2,026,700,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,026,700,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_49575E9AC377, https://asof.is/claim/clm_49575E9AC377, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_49575E9AC377","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8425BCAEBDE4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_6A4764C9BAB4","predicate":"cash_and_equivalents","value":"8,236,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,236,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_6A4764C9BAB4, https://asof.is/claim/clm_6A4764C9BAB4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_6A4764C9BAB4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0BF16A111DB1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_A4F0D35F6BFE","predicate":"quarterly_revenue","value":"11,422,200,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,422,200,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_A4F0D35F6BFE, https://asof.is/claim/clm_A4F0D35F6BFE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_A4F0D35F6BFE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D746F14C7469","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_C4DA1A536A80","predicate":"total_equity","value":"57,878,100,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 57,878,100,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_C4DA1A536A80, https://asof.is/claim/clm_C4DA1A536A80, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_C4DA1A536A80","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FB8799A4CF05","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_CEF5E014EF03","predicate":"total_assets","value":"111,593,800,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 111,593,800,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_CEF5E014EF03, https://asof.is/claim/clm_CEF5E014EF03, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_CEF5E014EF03","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6F134AACBD0F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_D1947D5F192E","predicate":"quarterly_net_income","value":"298,800,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 298,800,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_D1947D5F192E, https://asof.is/claim/clm_D1947D5F192E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_D1947D5F192E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_87DCBE668D46","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_CFB9418D7005","predicate":"shares_outstanding","value":"3,115,317,260 shares","valid_from":"2010-01-29","valid_to":"2010-04-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,115,317,260 shares\", as of 2010-01-29 (until 2010-04-30). Claim clm_CFB9418D7005, https://asof.is/claim/clm_CFB9418D7005, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_CFB9418D7005","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6BFEF753A9AF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_096391AC4DDE","predicate":"revenue","value":"27,428,300,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 27,428,300,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_096391AC4DDE, https://asof.is/claim/clm_096391AC4DDE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_096391AC4DDE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6B2D64844C16","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_2398410359B8","predicate":"research_and_development","value":"5,845,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 5,845,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_2398410359B8, https://asof.is/claim/clm_2398410359B8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_2398410359B8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DAC5122F3F04","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_47722B45F6C8","predicate":"cash_and_equivalents","value":"9,311,400,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,311,400,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_47722B45F6C8, https://asof.is/claim/clm_47722B45F6C8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_47722B45F6C8","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6A4764C9BAB4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_7347BADF2C70","predicate":"net_income","value":"12,901,300,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 12,901,300,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_7347BADF2C70, https://asof.is/claim/clm_7347BADF2C70, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_7347BADF2C70","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_39AC82F2B073","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_ACC2D700771A","predicate":"total_equity","value":"59,058,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 59,058,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_ACC2D700771A, https://asof.is/claim/clm_ACC2D700771A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_ACC2D700771A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C4DA1A536A80","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_FEC4D5849978","predicate":"total_assets","value":"112,089,700,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 112,089,700,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_FEC4D5849978, https://asof.is/claim/clm_FEC4D5849978, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_FEC4D5849978","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CEF5E014EF03","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_57A2834F3A81","predicate":"registrant_name","value":"Merck & Co., Inc.","valid_from":"2009-11-04","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. registrant name: Merck & Co., Inc.\", as of 2009-11-04. Claim clm_57A2834F3A81, https://asof.is/claim/clm_57A2834F3A81, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_57A2834F3A81","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_0FE78409134C","predicate":"quarterly_revenue","value":"6,049,700,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 6,049,700,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_0FE78409134C, https://asof.is/claim/clm_0FE78409134C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_0FE78409134C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A4F0D35F6BFE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-08"}},{"id":"clm_43B087FEC347","predicate":"total_equity","value":"12,900,000,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 12,900,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_43B087FEC347, https://asof.is/claim/clm_43B087FEC347, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_43B087FEC347","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ACC2D700771A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_4D5FB6156251","predicate":"cash_and_equivalents","value":"4,312,000,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,312,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_4D5FB6156251, https://asof.is/claim/clm_4D5FB6156251, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_4D5FB6156251","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_47722B45F6C8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_5904E31120BB","predicate":"shares_outstanding","value":"1,639,151,392 shares","valid_from":"2009-09-30","valid_to":"2010-01-29","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 1,639,151,392 shares\", as of 2009-09-30 (until 2010-01-29). Claim clm_5904E31120BB, https://asof.is/claim/clm_5904E31120BB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_5904E31120BB","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CFB9418D7005","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_5D1DFB0B7A44","predicate":"total_assets","value":"30,547,000,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 30,547,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_5D1DFB0B7A44, https://asof.is/claim/clm_5D1DFB0B7A44, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_5D1DFB0B7A44","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FEC4D5849978","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_9F8BAD62BE47","predicate":"quarterly_research_and_development","value":"913,000,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 913,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_9F8BAD62BE47, https://asof.is/claim/clm_9F8BAD62BE47, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_9F8BAD62BE47","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49575E9AC377","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_AAC4D7B22371","predicate":"quarterly_net_income","value":"515,000,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 515,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_AAC4D7B22371, https://asof.is/claim/clm_AAC4D7B22371, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_AAC4D7B22371","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D1947D5F192E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_048EC2C80B3F","predicate":"quarterly_net_income","value":"671,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 671,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_048EC2C80B3F, https://asof.is/claim/clm_048EC2C80B3F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_048EC2C80B3F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AAC4D7B22371","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_133163071D45","predicate":"total_equity","value":"12,035,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 12,035,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_133163071D45, https://asof.is/claim/clm_133163071D45, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_133163071D45","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43B087FEC347","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_2285A0A34C73","predicate":"cash_and_equivalents","value":"2,989,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 2,989,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_2285A0A34C73, https://asof.is/claim/clm_2285A0A34C73, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_2285A0A34C73","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4D5FB6156251","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_3184EF4E173F","predicate":"total_assets","value":"29,545,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 29,545,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3184EF4E173F, https://asof.is/claim/clm_3184EF4E173F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_3184EF4E173F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5D1DFB0B7A44","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_3CA7D1DAEFB3","predicate":"quarterly_revenue","value":"5,899,900,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 5,899,900,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3CA7D1DAEFB3, https://asof.is/claim/clm_3CA7D1DAEFB3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_3CA7D1DAEFB3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0FE78409134C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-08-06"}},{"id":"clm_6D871C86295C","predicate":"shares_outstanding","value":"0 shares","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 0 shares\", as of 2009-06-30 (until 2009-09-30). Claim clm_6D871C86295C, https://asof.is/claim/clm_6D871C86295C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_6D871C86295C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5904E31120BB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_C47CB8AEE9D1","predicate":"quarterly_research_and_development","value":"863,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 863,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_C47CB8AEE9D1, https://asof.is/claim/clm_C47CB8AEE9D1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_C47CB8AEE9D1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9F8BAD62BE47","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_6BB2CF8F4BA7","predicate":"x_username","value":"merck","valid_from":"2009-04-27","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. x username: merck\", as of 2009-04-27. Claim clm_6BB2CF8F4BA7, https://asof.is/claim/clm_6BB2CF8F4BA7, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q247489.","url":"https://asof.is/claim/clm_6BB2CF8F4BA7","accessed":"2026-11-08"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/Merck","url":"https://www.merck.com"}},{"id":"clm_4EDF0B1989AE","predicate":"cash_and_equivalents","value":"6,017,100,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,017,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_4EDF0B1989AE, https://asof.is/claim/clm_4EDF0B1989AE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_4EDF0B1989AE","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2285A0A34C73","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_AA38C432CDB7","predicate":"quarterly_net_income","value":"1,425,000,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,425,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_AA38C432CDB7, https://asof.is/claim/clm_AA38C432CDB7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_AA38C432CDB7","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_048EC2C80B3F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_C8A4E67B495C","predicate":"quarterly_revenue","value":"5,385,200,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 5,385,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C8A4E67B495C, https://asof.is/claim/clm_C8A4E67B495C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_C8A4E67B495C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3CA7D1DAEFB3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_E816BE82558E","predicate":"quarterly_research_and_development","value":"1,224,200,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,224,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_E816BE82558E, https://asof.is/claim/clm_E816BE82558E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_E816BE82558E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C47CB8AEE9D1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-05-07"}},{"id":"clm_0C23DECD923D","predicate":"total_equity","value":"18,758,300,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 18,758,300,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_0C23DECD923D, https://asof.is/claim/clm_0C23DECD923D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_0C23DECD923D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_133163071D45","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_5C437D324996","predicate":"cash_and_equivalents","value":"4,368,300,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,368,300,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_5C437D324996, https://asof.is/claim/clm_5C437D324996, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5C437D324996","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4EDF0B1989AE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_5FD9363AA3ED","predicate":"total_assets","value":"47,195,700,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 47,195,700,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_5FD9363AA3ED, https://asof.is/claim/clm_5FD9363AA3ED, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5FD9363AA3ED","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3184EF4E173F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_6AB36311B283","predicate":"revenue","value":"23,850,300,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 23,850,300,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_6AB36311B283, https://asof.is/claim/clm_6AB36311B283, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_6AB36311B283","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_096391AC4DDE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_AC1DCB2822D2","predicate":"net_income","value":"7,808,400,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 7,808,400,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_AC1DCB2822D2, https://asof.is/claim/clm_AC1DCB2822D2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_AC1DCB2822D2","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7347BADF2C70","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_AD7D2ACA144B","predicate":"research_and_development","value":"4,805,300,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 4,805,300,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_AD7D2ACA144B, https://asof.is/claim/clm_AD7D2ACA144B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_AD7D2ACA144B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2398410359B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_0012D0EF4581","predicate":"quarterly_research_and_development","value":"893,000,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 893,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_0012D0EF4581, https://asof.is/claim/clm_0012D0EF4581, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_0012D0EF4581","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E816BE82558E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_2C246AABD63D","predicate":"quarterly_revenue","value":"4,576,000,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 4,576,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_2C246AABD63D, https://asof.is/claim/clm_2C246AABD63D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_2C246AABD63D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C8A4E67B495C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_B27C1DE2C9B9","predicate":"cash_and_equivalents","value":"3,159,000,000 United States dollar","valid_from":"2008-09-30","valid_to":"2008-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 3,159,000,000 United States dollar\", as of 2008-09-30 (until 2008-12-31). Claim clm_B27C1DE2C9B9, https://asof.is/claim/clm_B27C1DE2C9B9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_B27C1DE2C9B9","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5C437D324996","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_BEEB13A3FCFF","predicate":"quarterly_net_income","value":"614,000,000 United States dollar","valid_from":"2008-09-30","valid_to":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 614,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_BEEB13A3FCFF, https://asof.is/claim/clm_BEEB13A3FCFF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_BEEB13A3FCFF","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AA38C432CDB7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-29"}},{"id":"clm_10D2DE05595D","predicate":"quarterly_net_income","value":"462,000,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 462,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_10D2DE05595D, https://asof.is/claim/clm_10D2DE05595D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_10D2DE05595D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BEEB13A3FCFF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_39FFF425906C","predicate":"cash_and_equivalents","value":"2,705,000,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 2,705,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_39FFF425906C, https://asof.is/claim/clm_39FFF425906C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_39FFF425906C","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B27C1DE2C9B9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_66C40BC5AB58","predicate":"quarterly_revenue","value":"4,921,000,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 4,921,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_66C40BC5AB58, https://asof.is/claim/clm_66C40BC5AB58, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_66C40BC5AB58","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2C246AABD63D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_A11256338AE1","predicate":"quarterly_research_and_development","value":"906,000,000 United States dollar","valid_from":"2008-06-30","valid_to":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 906,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_A11256338AE1, https://asof.is/claim/clm_A11256338AE1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_A11256338AE1","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0012D0EF4581","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-07-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-24"}},{"id":"clm_5165C273DFBC","predicate":"total_equity","value":"20,591,400,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 20,591,400,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_5165C273DFBC, https://asof.is/claim/clm_5165C273DFBC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5165C273DFBC","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0C23DECD923D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_5DBE0DD30DAD","predicate":"revenue","value":"24,197,700,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 24,197,700,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_5DBE0DD30DAD, https://asof.is/claim/clm_5DBE0DD30DAD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5DBE0DD30DAD","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6AB36311B283","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_E830E102F96E","predicate":"research_and_development","value":"4,882,800,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 4,882,800,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_E830E102F96E, https://asof.is/claim/clm_E830E102F96E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_E830E102F96E","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD7D2ACA144B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_EF9A8E802FB5","predicate":"net_income","value":"3,275,400,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 3,275,400,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_EF9A8E802FB5, https://asof.is/claim/clm_EF9A8E802FB5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_EF9A8E802FB5","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AC1DCB2822D2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_F2BA78F20E9F","predicate":"cash_and_equivalents","value":"5,336,100,000 United States dollar","valid_from":"2007-12-31","valid_to":"2008-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,336,100,000 United States dollar\", as of 2007-12-31 (until 2008-06-30). Claim clm_F2BA78F20E9F, https://asof.is/claim/clm_F2BA78F20E9F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_F2BA78F20E9F","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_39FFF425906C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_1F1D245F44D6","predicate":"cash_and_equivalents","value":"5,914,700,000 United States dollar","valid_from":"2006-12-31","valid_to":"2007-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,914,700,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_1F1D245F44D6, https://asof.is/claim/clm_1F1D245F44D6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_1F1D245F44D6","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F2BA78F20E9F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_4496266C128D","predicate":"total_equity","value":"19,965,800,000 United States dollar","valid_from":"2006-12-31","valid_to":"2007-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 19,965,800,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_4496266C128D, https://asof.is/claim/clm_4496266C128D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_4496266C128D","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5165C273DFBC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-03-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"id":"clm_B41895454D67","predicate":"registrant_name","value":"SCHERING PLOUGH CORP","valid_from":"1994-12-29","valid_to":"2009-10-29","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. registrant name: SCHERING PLOUGH CORP\", as of 1994-12-29 (until 2009-10-29). Claim clm_B41895454D67, https://asof.is/claim/clm_B41895454D67, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_B41895454D67","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_57A2834F3A81","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_37834FC2D131","predicate":"ticker","value":"MRK","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. ticker: MRK\", undated. Claim clm_37834FC2D131, https://asof.is/claim/clm_37834FC2D131, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_37834FC2D131","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_611073235D86","predicate":"state_of_incorporation","value":"NJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. state of incorporation: NJ\", undated. Claim clm_611073235D86, https://asof.is/claim/clm_611073235D86, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_611073235D86","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7424130E993D","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_7424130E993D, https://asof.is/claim/clm_7424130E993D, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_7424130E993D","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_866F817FFD7C","predicate":"cik","value":"0000310158","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cik: 0000310158\", undated. Claim clm_866F817FFD7C, https://asof.is/claim/clm_866F817FFD7C, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_866F817FFD7C","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_88B4EFBC615C","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. listed on: NYSE\", undated. Claim clm_88B4EFBC615C, https://asof.is/claim/clm_88B4EFBC615C, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_88B4EFBC615C","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_BFFD023A5D40","predicate":"headquarters","value":"Rahway","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. headquarters: Rahway\", undated. Claim clm_BFFD023A5D40, https://asof.is/claim/clm_BFFD023A5D40, accessed 2026-11-08. Source: https://www.merck.com/contact-us/.","url":"https://asof.is/claim/clm_BFFD023A5D40","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.merck.com/contact-us/","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_D6EE533D837B","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. fiscal year end: 12-31\", undated. Claim clm_D6EE533D837B, https://asof.is/claim/clm_D6EE533D837B, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_D6EE533D837B","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_500A250794EC","predicate":"website","value":"https://www.merck.com","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. website: https://www.merck.com\", undated. Claim clm_500A250794EC, https://asof.is/claim/clm_500A250794EC, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q247489.","url":"https://asof.is/claim/clm_500A250794EC","accessed":"2026-11-08"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Merck | Home.","url":"https://www.merck.com"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it.","low_confidence":"Confidence below 0.5, the line the record asserts at."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}